UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM10-Q

 

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended OctoberJuly 28, 20172018

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                to                

Commission file number0-13200

 

 

AstroNova, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Rhode Island 05-0318215

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

600 East Greenwich Avenue,

West Warwick, Rhode Island

 02893
(Address of principal executive offices) (Zip Code)

(401)828-4000

(Registrant’s telephone number, including area code)

Astro-Med, Inc.

(Former name, former address and former fiscal year, if changed since last report)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  .☐.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of RegulationS-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes      No  .☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer 
Non-accelerated filer ☐  (Do not check if a smaller reporting company)  Smaller reporting company 
   Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act)    Yes      No  .☒.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, $.05 Par Value—6,761,099Value – 6,923,883 shares

(excluding treasury shares) as of December 1, 2017August 30, 2018

 

 

 


ASTRONOVA, INC.

INDEX

 

     Page No. 

Part I.

 

Financial Information

  

Item 1.

 Financial Statements  3
 

Unaudited Condensed Consolidated Balance Sheets—OctoberJuly 28, 20172018 and January 31, 20172018

   3 
 

Unaudited Condensed Consolidated Statements of Income—Three and NineSix Months Ended OctoberJuly 28, 20172018 and OctoberJuly 29, 20162017

   4 
 

Unaudited Condensed Consolidated Statements of Comprehensive Income—Three and NineSix Months Ended OctoberJuly 28, 20172018 and OctoberJuly 29, 20162017

   5 
 

Unaudited Condensed Consolidated Statements of Cash Flows—NineSix Months Ended OctoberJuly 28, 20172018 and OctoberJuly 29, 20162017

   6 
 

Notes to the Condensed Consolidated Financial Statements (unaudited)

   7-207-24 

Item 2.

 Management’s Discussion and Analysis of Financial Condition and Results of Operations   21-2725-32 

Item 3.

 Quantitative and Qualitative Disclosures about Market Risk   2833 

Item 4.

 Controls and Procedures   2933 

Part II.

 Other Information  29

Item 1.

 Legal Proceedings   2934 

Item 1A.

 Risk Factors   2934 

Item 2.

 Unregistered Sales of Equity Securities and Use of Proceeds   2934 

Item 6.

 Exhibits   3035 

Signatures

  3136 


Part I. FINANCIAL INFORMATION

Item 1.Financial Statements

Item 1. Financial Statements

ASTRONOVA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, Except Share Data)

 

  October 28,
2017
 January 31,
2017
   July 28,
2018
 January 31,
2018
 
  (Unaudited)     (Unaudited)   
ASSETS      

CURRENT ASSETS

      

Cash and Cash Equivalents

  $8,466  $18,098   $5,949  $10,177 

Securities Available for Sale

   3,284  6,723    —    1,511 

Accounts Receivable, net

   17,861  15,702    24,048  22,400 

Inventories

   23,658  19,506 

Inventories, net

   28,396  27,609 

Prepaid Expenses and Other Current Assets

   2,054  1,394    1,767  1,251 
  

 

  

 

   

 

  

 

 

Total Current Assets

   55,323  61,423    60,160  62,948 

PROPERTY, PLANT AND EQUIPMENT

   42,244  40,378    43,559  42,877 

Less Accumulated Depreciation

   (32,487 (31,098   (34,034 (33,125
  

 

  

 

   

 

  

 

 

Property, Plant and Equipment, net

   9,757  9,280    9,525  9,752 

OTHER ASSETS

      

Intangible Assets, net

   29,804  5,264    31,788  33,633 

Goodwill

   12,441  4,521    12,466  13,004 

Deferred Tax Assets

   2,826  2,811    1,827  1,829 

Other

   169  366 

Other Assets

   1,304  1,147 
  

 

  

 

   

 

  

 

 

Total Other Assets

   45,240  12,962    47,385  49,613 
  

 

  

 

   

 

  

 

 

TOTAL ASSETS

  $110,320  $83,665   $117,070  $122,313 
  

 

  

 

   

 

  

 

 
LIABILITIES AND SHAREHOLDERS’ EQUITY      

CURRENT LIABILITIES

      

Accounts Payable

  $7,198  $4,957   $6,082  $11,808 

Accrued Compensation

   2,215  2,936    3,294  2,901 

Other Liabilities and Accrued Expenses

   2,266  2,171    3,380  2,414 

Current Portion of Long -Term Debt

   1,656   —   

Current Portion of Borrowings under Revolving Credit Facility

   2,250   —   

Current Portion of Long-Term Debt

   5,024  5,498 

Current Portion of Royalty Obligation

   500   —      1,625  1,625 

Revolving Credit Facility

   1,500   —   

Current Liability – Excess Royalty Payment Due

   1,377  615 

Deferred Revenue

   411  472    366  367 

Income Taxes Payable

   405  1,449    236  684 
  

 

  

 

   

 

  

 

 

Total Current Liabilities

   16,901  11,985    22,884  25,912 

Borrowings under Revolving Credit Facility, net of current portion

   12,350   —   

Royalty Obligation

   8,200   —   

Long-Term Debt

   6,845   —   

NON CURRENT LIABILITIES

   

Long-Term Debt, net of current portion

   15,249  17,648 

Royalty Obligation, net of current portion

   10,901  11,760 

Deferred Tax Liabilities

   845  11    623  698 

Other Liabilities

   2,939  1,132    1,925  2,648 
  

 

  

 

   

 

  

 

 

TOTAL LIABILITIES

   48,080  13,128    51,582  58,666 

SHAREHOLDERS’ EQUITY

      

Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 9,955,479 shares and 9,834,906 shares at October 28, 2017 and January 31, 2017, respectively

   498  492 

Common Stock, $0.05 Par Value, Authorized 13,000,000 shares; Issued 10,136,497 shares and 9,996,120 shares at July 28, 2018 and January 31, 2018, respectively

   507  500 

AdditionalPaid-in Capital

   49,491  47,524    51,877  50,016 

Retained Earnings

   45,543  44,358    46,761  45,700 

Treasury Stock, at Cost, 3,227,942 and 2,375,076 shares at October 28, 2017 and January 31, 2017, respectively

   (32,397 (20,781

Treasury Stock, at Cost, 3,259,473 and 3,227,942 shares at July 28, 2018 and January 31, 2018, respectively

   (32,960 (32,397

Accumulated Other Comprehensive Loss, net of tax

   (895 (1,056   (697 (172
  

 

  

 

   

 

  

 

 

TOTAL SHAREHOLDERS’ EQUITY

   62,240  70,537    65,488  63,647 
  

 

  

 

   

 

  

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

  $110,320  $83,665   $117,070  $122,313 
  

 

  

 

   

 

  

 

 

See Notes to condensed consolidated financial statements (unaudited).

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, Except Per Share Data)

(Unaudited)

 

  Three Months Ended Nine Months Ended   Three Months Ended   Six Months Ended 
  October 28,
2017
 October 29,
2016
 October 28,
2017
 October 29,
2016
   July 28,
2018
 July 29,
2017
   July 28,
2018
 July 29,
2017
 

Revenue

  $28,760  $23,342  $80,701  $72,791   $33,807  $27,483   $65,294  $51,941 

Cost of Revenue

   16,966  13,701  49,342  43,373    20,408  17,224    39,784  32,376 
  

 

  

 

  

 

  

 

   

 

  

 

   

 

  

 

 

Gross Profit

   11,794  9,641  31,359  29,418    13,399  10,259    25,510  19,565 

Operating Expenses:

           

Selling and Marketing

   5,532  4,578  15,958  14,186    6,397  5,315    12,898  10,426 

Research and Development

   2,033  1,338  5,340  4,538    2,029  1,675    3,721  3,307 

General and Administrative

   2,597  1,891  6,780  5,566    2,808  2,327    5,462  4,183 
  

 

  

 

  

 

  

 

   

 

  

 

   

 

  

 

 

Operating Expenses

   10,162  7,807  28,078  24,290    11,234  9,317    22,081  17,916 
  

 

  

 

  

 

  

 

   

 

  

 

   

 

  

 

 

Operating Income

   1,632  1,834  3,281  5,128 

Other Expense, net

   (12 (60 (45 (72

Operating Income, net

   2,165  942    3,429  1,649 

Other Income (Expense)

   (512 16    (782 (33
  

 

  

 

  

 

  

 

   

 

  

 

   

 

  

 

 

Income before Income Taxes

   1,620  1,774  3,236  5,056    1,653  958    2,647  1,616 

Income Tax Provision

   201  623  579  1,595    459  231    639  378 
  

 

  

 

  

 

  

 

   

 

  

 

   

 

  

 

 

Net Income

  $1,419  $1,151  $2,657  $3,461   $1,194  $727   $2,008  $1,238 
  

 

  

 

  

 

  

 

   

 

  

 

   

 

  

 

 

Net Income per Common Share—Basic:

  $0.21  $0.15  $0.38  $0.47   $0.17  $0.11   $0.29  $0.17 
  

 

  

 

  

 

  

 

   

 

  

 

   

 

  

 

 

Net Income per Common Share—Diluted:

  $0.21  $0.15  $0.38  $0.46   $0.17  $0.11   $0.29  $0.17 
  

 

  

 

  

 

  

 

   

 

  

 

   

 

  

 

 

Weighted Average Number of Common Shares Outstanding:

           

Basic

   6,725  7,444  6,968  7,407    6,860  6,727    6,825  7,097 

Diluted

   6,821  7,594  7,078  7,572    7,083  6,838    6,999  7,218 

Dividends Declared Per Common Share

  $0.07  $0.07  $0.21  $0.21   $0.07  $0.07   $0.14  $0.14 

See Notes to condensed consolidated financial statements (unaudited).

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In Thousands)

(Unaudited)

 

  Three Months Ended Nine Months Ended   Three Months
Ended
 Six Months
Ended
 
  October 28,
2017
 October 29,
2016
 October 28,
2017
 October 29,
2016
   July 28,
2018
 July 29,
2017
 July 28,
2018
 July 29,
2017
 

Net Income

  $1,419  $1,151  $2,657  $3,461   $1,194  $727  $2,008  $1,239 

Other Comprehensive Income (Loss), Net of Taxes and Reclassification Adjustments:

          

Foreign Currency Translation Adjustments

   (108 (145 210  (11   (349 540  (618 319 

Change in Value of Derivatives Designated as Cash Flow Hedge

   60   —    (700  —      245  (501 545  (760

Gain (Loss) from Cash Flow Hedges Reclassified to Income Statement

   (58  —    646   —   

Losses (Gains) from Cash Flow Hedges Reclassified to Income Statement

   (255 492  (455 703 

Unrealized Holding Gain (Loss) on Securities Available for Sale

   (2 (17 5  (10   —    (5 —    7 

Realized Gain (Loss) on Securities Available for Sale reclassified to income statement

   (3  —    3   —   
  

 

  

 

  

 

  

 

   

 

  

 

  

 

  

 

 

Other Comprehensive Income (Loss)

   (108 (162 161  (21   (362 526  (525 269 
  

 

  

 

  

 

  

 

   

 

  

 

  

 

  

 

 

Comprehensive Income

  $1,311  $989  $2,818  $3,440   $832  $1,253  $1,483  $1,508 
  

 

  

 

  

 

  

 

   

 

  

 

  

 

  

 

 

See Notes to condensed consolidated financial statements (unaudited).

ASTRONOVA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)

 

  Nine Months Ended   Six Months Ended 
  October 28,
2017
 October 29,
2016
   July 28,
2018
 July 29,
2017
 

Cash Flows from Operating Activities:

      

Net Income

  $2,657  $3,461   $2,008  $1,238 

Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:

   

Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities:

   

Depreciation and Amortization

   2,394  1,829    3,088  1,461 

Amortization of Debt Issuance Costs

   22   —      26  14 

Share-Based Compensation

   1,125  731    829  580 

Deferred Income Tax Provision

   (14 335    (67 4 

Changes in Assets and Liabilities, Net of Impact of Acquisitions:

   

Changes in Assets and Liabilities, Net of Impact of Acquisition:

   

Accounts Receivable

   (575 587    (2,002 336 

Inventories

   (1,769 (4,257   (1,080 221 

Income Taxes

   (1,078 818    (201 (255

Accounts Payable and Accrued Expenses

   (610 2,232    (4,554 (2,113

Other

   (175 1,599    (671 193 
  

 

  

 

   

 

  

 

 

Net Cash Provided by Operating Activities

   1,977  7,335 

Net Cash Provided (Used) by Operating Activities

   (2,624 1,679 

Cash Flows from Investing Activities:

      

Proceeds from Sales/Maturities of Securities Available for Sale

   3,766  3,517    1,511  1,601 

Purchases of Securities Available for Sale

   (321 (400

Cash Paid for Honeywell Asset Purchase and License Agreement

   (14,873  —   

Cash Paid for TrojanLabel Acquisition, net of cash acquired

   (9,007  —      —    (9,007

Payments Received on Line of Credit and Note Receivable

   85  226 

Honeywell Asset Purchase and License Agreement—TSA Agreement

   (400  —   

Payments Received on Line of Credit Issued to Label Line

   —    60 

Additions to Property, Plant and Equipment

   (1,719 (897   (848 (983
  

 

  

 

   

 

  

 

 

Net Cash (Used) Provided by Investing Activities

   (22,069 2,446 

Net Cash Provided (Used) by Investing Activities

   263  (8,329

Cash Flows from Financing Activities:

      

Cash Proceeds from Common Shares Issued Under Employee Benefit Plans and Employee Stock Option Plans, Net of Payment of Minimum Tax Withholdings

   471  16 

Proceeds from Borrowings under Revolving Credit Facility

   14,600   —   

Net cash proceeds from Common Shares Issued Under Employee Benefit Plans and Employee Stock Option Plans, Net of Payment of Minimum Tax Withholdings

   477  424 

Purchase of Treasury Stock

   (11,238  —      —    (11,238

Proceeds from Issuance of Long-Term Debt

   9,200   —      —    9,200 

Change in Fair Value of Trojan Label Earn Out

   (477  —   

Principal Payments on Long-Term Debt

   (552  —   

Borrowings under Revolving Credit Facility

   3,000   —   

Repayments under Revolving Credit Facility

   (1,500  —   

Principal Payments of Long-Term Debt

   (2,908 (276

Payments of Debt Issuance Costs

   (155  —      —    (155

Dividends Paid

   (1,470 (1,559   (960 (997
  

 

  

 

   

 

  

 

 

Net Cash Provided (Used) by Financing Activities

   10,379  (1,543   (1,891 (3,042
  

 

  

 

   

 

  

 

 

Effect of Exchange Rate Changes on Cash and Cash Equivalents

   81  (157   24  423 
  

 

  

 

   

 

  

 

 

Net (Decrease) Increase in Cash and Cash Equivalents

   (9,632 8,081 

Net Increase (Decrease) in Cash and Cash Equivalents

   (4,228 (9,269

Cash and Cash Equivalents, Beginning of Period

   18,098  10,043    10,177  18,098 
  

 

  

 

   

 

  

 

 

Cash and Cash Equivalents, End of Period

  $8,466  $18,124   $5,949  $8,829 
  

 

  

 

   

 

  

 

 

Supplemental Disclosures of Cash Flow Information:

      

Cash Paid During the Period for Interest

  $138  $—     $329  $30 

Cash Paid During the Period for Income Taxes, Net of Refunds

  $1,736  $296   $1,639  $584 

Schedule ofNon-Cash Financing Activities:

   

Value of Shares Received in Satisfaction of Option Exercise Price

  $366  $231 

See Notes to condensed consolidated financial statements (unaudited).

ASTRONOVA, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(1) Overview

Headquartered in West Warwick, Rhode Island, AstroNova, Inc. leverages its expertise in data visualization technologies to design, develop, manufacture and distribute a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada, China, Europe, Mexico and Southeast Asia as well as through independent dealers and representatives. AstroNova, Inc. products are employed around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation applications.

The business consists of two segments, Product Identification, which includes specialty printing systems sold under the QuickLabel® and TrojanLabel® brand names, and Test & Measurement which includes test and measurement as well as Aerospace systems sold under the AstroNova™AstroNova® brand name.

Products sold under the QuickLabel and TrojanLabel brands are used in industrial and commercial product packaging, branding and automatic identificationlabeling applications to digitally print custom labels and othercorresponding visual identification marks on demand.content in house. Products sold under the AstroNova Test & Measurement brand enable our customers to acquire and record visual and electronic signal data from local and networked data streams and sensors. The recorded data is processed and analyzed and then stored and presented in various visual output formats. In the aerospace market, the Company has a long history of using its data visualization technologies to provide high-resolution airborne printerslight-weight flight deck and networking systems as well as related hardware and supplies.cabin printers.

Unless otherwise indicated, references to “AstroNova,” the “Company,” “we,” “our,” and “us” in this Quarterly Report onForm 10-Q refer to AstroNova, Inc. and its consolidated subsidiaries.

(2) Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results of the interim periods included herein. These financial statements do not include all disclosures associated with annual financial statements and, accordingly, should be read in conjunction with footnotes contained in the Company’s Annual Report on Form10-K for the fiscal year ended January 31, 2017.2018.

Results of operations for the interim periods presented herein are not necessarily indicative of the results that may be expected for the full year.

The presentation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Some of the more significant estimates relate to revenue recognition, the allowances for doubtful accounts and credits, inventory valuation, impairment of long-lived assets and goodwill, income taxes, share-based compensation, accrued expenses and warranty reserves. Management’s estimates are based on the facts and circumstances available at the time estimates are made, historical experience, risk of loss, general economic conditions and trends, and management’s assessments of the probable future outcome of these matters. Consequently, actual results could differ from those estimates.

Certain amounts in the prior year financial statements have been reclassified to conform to the current year’s presentation.

(3) Principles of Consolidation

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.

(4) AcquisitionsRevenue Recognition

On February 1, 2018 we adopted Accounting Standards Update2014-09, “Revenue from Contracts with Customers (Accounting Standards Codification “ASC” Topic 606),” which superseded nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASC Topic 606 is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASC Topic 606 defines a five step process to recognize revenue and requires more judgment and estimates within the revenue recognition process than required under previous U.S. GAAP, including identifying performance obligations in the contract, determining and estimating the amount of any variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.

We adopted this standard using the modified retrospective method and have applied the guidance to all contracts within the scope of ASC Topic 606 as of the February 1, 2018 adoption date. Under ASC Topic 606, based on the nature of our contracts and consistent with prior practice, we recognize the large majority of our revenue upon shipment, which is when the performance obligation has been satisfied. Accordingly, the adoption of this standard did not have a material impact on our revenue recognition and there was no cumulative effective adjustment as of February 1, 2018 as a result of the adoption of ASC Topic 606.

Significant judgments primarily include the identification of performance obligation arrangements as well as the pattern of delivery for those services.

We derive revenue from the sale of (i) hardware including, digital color label printers and specialty OEM printing systems, portable data acquisition systems and airborne printers used in the flight deck and in the cabin of military, commercial and business aircraft, (ii) related supplies required in the operation of the hardware, (iii) repairs and maintenance of equipment and (iv) service agreements.

The vast majority of our revenue is generated from the sale of distinct products. Revenue is measured as the amount of consideration the Company expects to receive in exchange for such products, which is generally at the contractually stated prices, and is recognized when we satisfy a performance obligation by transferring control of a product to a customer. The transfer of control generally occurs at one point in time, upon shipment, when title and risk of loss pass to the customer. Returns and customer credits are infrequent and are recorded as a reduction to revenue. Sales taxes and value added taxes collected concurrently with revenue generating activities are excluded from revenue.

Many of the contracts entered into with customers are commonly comprised of a combination of equipment, supplies, installation and/or training services. We determine performance obligations by assessing whether the products or services are distinct from other elements of the contract. In order to be distinct, the product must perform either on its own or with readily available resources and must be separate within the context of the contract.

The majority of our hardware products contain embedded operating systems and data management software which is included in the purchase price of the equipment. The software is deemed incidental to the systems as a whole as it is not sold or marketed separately and its production costs are minor compared to those of the hardware system. Hardware and software elements are typically delivered at the same time and are accounted for as a single performance obligation for which revenue is recognized at the point in time when ownership is transferred to the customer.

Installation and training services vary based on certain factors such as the complexity of the equipment, staffing availability in a geographic location and customer preferences, and can range from a few days to a few months. The delivery of installation and training services are not assessed to determine whether they are separate performance obligations, as the amounts are not material to the contract.

Shipping and handling activities that occur after control over a product has transferred to a customer are accounted for as fulfillment activities rather than performance obligations, as allowed under a practical expedient provided by ASC Topic 606. The shipping and handling fees charged to customers are recognized as revenue and the related costs are included in cost of revenue at the point in time when ownership of the product is transferred to the customer.

We may perform service at the request of the customer, generally for the repair and maintenance of products previously sold. These services are short in duration, typically less than one month, and total less than 9.0% of revenue for the six months ended July 28, 2018. Revenue is recognized as services are rendered and accepted by the customer. We also provide service agreements on certain of our Product Identification equipment. Service agreements are purchased separately from the equipment and provide for the right to obtain service and maintenance on the equipment for a period of typically one to two years. Accordingly, revenue on these agreements is recognized over the term of the agreements. The portion of service agreement contracts that are uncompleted at the end of any reporting period are included in deferred revenue.

We generally provide warranties for our products. The standard warranty period is typically 12 months for most hardware products except for airborne printers, which typically have warranties that extend for4-5 years, consistent with industry practice. Such assurance-type warranties are not deemed to be separate performance obligations from the hardware product and costs associated with providing the warranties are accrued in accordance with ASC 450, “Contingencies,” as we have the ability to ascertain the likelihood of the liability and can reasonably estimate the amount of the liability. Our estimate of costs to service the warranty obligations is based on historical experience and expectations of future conditions. To the extent that our experience in warranty claims or costs associated with servicing those claims differ from the original estimates, revisions to the estimated warranty liability are recorded at that time, with an offsetting adjustment to cost of revenue. On occasion, customers request a warranty period longer than our standard warranty. In those instances, in which extended warranty services are separately quoted to the customer, an additional performance obligation is created, and the associated revenue is deferred and recognized as service revenue ratably over the term of the extended warranty period. The portion of service contracts and extended warranty services agreements that are uncompleted at the end of any reporting period are included in deferred revenue.

Revenues disaggregated by primary geographic markets and major product type are as follows:

Honeywell Asset PurchasePrimary geographical markets:

   Three Months Ended   Six Months Ended 
(In thousands)  July 28,
2018
   July 29,
2017
   July 28,
2018
   July 29,
2017
 

United States

  $19,977   $17,249   $39,210   $32,932 

Europe

   7,885    7,391    15,719    13,774 

Canada

   1,648    1,250    3,094    2,426 

Asia

   2,537    797    3,976    1,087 

Central and South America

   1,102    652    2,156    1,484 

Other

   658    144    1,139    238 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Revenue

  $33,807   $27,483   $65,294   $51,941 
  

 

 

   

 

 

   

 

 

   

 

 

 

Major product type:

   Three Months Ended   Six Months Ended 
(In thousands)  July 28,
2018
   July 29,
2017
   July 28,
2018
   July 29,
2017
 

Hardware

  $12,904   $8,601   $24,881   $15,890 

Supplies

   17,883    16,282    34,584    31,127 

Service and Other

   3,020    2,600    5,829    4,924 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Revenue

  $33,807   $27,483   $65,294   $51,941 
  

 

 

   

 

 

   

 

 

   

 

 

 

Accounts Receivable

Credit is extended based upon an evaluation of the customer’s financial condition. Accounts receivable are stated at their estimated net realizable value. The allowance for doubtful accounts is based on a variety of factors, including the age of amounts outstanding relative to their contractual due date, specific customer factors, historicalwrite-off experience and License Agreementcurrent market assessments. Standard payment terms are typically 30 days after shipment, but vary by type and geographic location of our customers.

Contract Assets and Liabilities

We normally do not have contract assets, which are primarily unbilled accounts receivable that are conditional on something other than the passage of time. Our contract liabilities, which represent billings in excess of revenue recognized, are related to advanced billings for purchased service agreements and extended warranties and were $366,000 and $367,000 at July 28, 2018 and January 31, 2018, respectively, and are recorded as deferred revenue in the condensed consolidated balance sheet. The slight decrease in the deferred revenue at July 28, 2018 is primarily due to approximately $403,000 of revenue recognized during the period that was included in the deferred revenue balance at January 31, 2018, offset by cash payments received in advance of satisfying performance obligations.

Contract Costs

We recognize an asset for the incremental direct costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain costs related to obtaining sales contracts for our aerospace printer products meet the requirement to be capitalized. These costs are deferred and amortized based on the forecasted number of units sold over the estimated benefit term, which is currently estimated to be approximately 10 years. There has been no change in the Company’s accounting for these contracts as a result of the adoption of ASC Topic 606. The balance of these contract assets at January 31, 2018 was $832,000 and was reported in other assets in the consolidated balance sheet. In the first quarter of fiscal 2019, the Company incurred an additional $150,000 in incremental direct costs which were deferred. The amortization of incremental direct costs was $9,000 and $18,000 for the three and six months periods ended July 28, 2018. The balance of the deferred incremental direct contract costs net of accumulated amortization at July 28, 2018 is $967,000 and is reported in other assets in the condensed consolidated balance sheet. This amount is expected to be amortized over its estimated remaining period of benefit, which we currently estimate to be approximately 8 years.

We apply the practical expedient to expense costs incurred for costs to obtain a contract when the amortization period would have been less than a year. These costs include sales commissions paid to the internal direct sales team as well as to third-party representatives and distributors. Contractual agreements with each of these parties outline commission structures and rates to be paid. Generally speaking, the contracts are all individual procurement decisions by the customers and do not include renewal provisions and as such the majority of the contracts have an economic life of significantly less than a year.

(5) Acquisitions

On September 28, 2017, AstroNova, Inc. entered into an Asset Purchase and License Agreement (the “Honeywell Agreement”) with Honeywell International, Inc. to acquire an exclusive perpetual world-wide license to manufacture Honeywell’s narrow-format flight deck printers for two aircraft families along with certain inventory used in the manufacturing.manufacturing of the licensed printers. The purchase price consisted of an initial upfront payment of $14.6 million in cash. The Honeywell Agreement also providesprovided for guaranteed minimum royalty payments of $15.0 million, to be paid to Honeywell over the next ten years, based on gross revenues from the sales of the printers, paper and repair services of the licensed products. The royalty rates vary based on the year in which they are paid or earned and product sold or service provided, and range from single-digit to mid double-digit percentages of gross revenue.

The Company has

This transaction was evaluated this transaction under Accounting Standard Update (ASU)2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business,” and determined that this transaction should bewas accounted for as an asset acquisition. Refer to Note 15, “Recent Accounting Pronouncements,” for further details on ASU2017-01.

The initial upfront payment of $14.6 million was paid at the closing of this transaction using borrowings from the Company’s revolving credit facility under its amended Credit Agreement with Bank of America, N.A. Refer to Note 11, “Revolving Credit Facility” for further details.

The minimum royalty payment obligation of $15.0 million was recorded at the present value of the annual minimum annual royalty payments using a present value factor of 2.8%, which is based on the estimated after tax cost of debt for similar companies. TheAt July 28, 2018, the current portion of the minimum royalty obligation of $500,000to be paid over the next twelve months is $1.6 million and is reported as a current liabilityliability; and the remainder of $8.2$10.9 million is reported as a long-term liability on the Company’s condensed consolidated balance sheetsheet. For the three and six months ended July 28, 2018, the Company incurred $0.5 million and $0.8 million, respectively, in excess royalty expense, which is included in cost of revenue in the Company’s condensed consolidated statement of income for the period ended July 28, 2018. A total of $1.4 million of excess royalty is payable at OctoberJuly 28, 2017.

Transaction costs incurred for this acquisition were $273,0002018 and have been includedreported as part ofa current liability on the purchase price.Company’s condensed consolidated balance sheet.

In connection with the Honeywell Agreement, the Company also entered into a Transition Services Agreement (TSA)(“TSA”) with Honeywell related to the transfer of the manufacturing and repair of the licensed printers from their current locations to AstroNova’s plant in West Warwick, Rhode Island. SubjectDuring the current year, the Company paid $0.4 million to acquire an additional repair facility revenue stream in accordance with the terms of the TSA. The additional $0.4 million TSA obligation payment was included as part of the Honeywell Agreement purchase price and recorded as an increase to the completion ofrelated intangible asset.

Under the terms of the TSA, the Company is required to pay for certain expenses incurred by Honeywell International,during the Company may makeperiod in which product manufacturing is transferred to the Company’s facilities. In the first quarter of fiscal 2019, a change in accounting estimates for product costs and operating expenses related to the TSA resulted in an additional paymentincrease of $400,000.$1.0 million in operating income ($0.8 million net of tax or $0.12 per diluted share). In addition, in the first quarter of fiscal 2019, a change in accounting estimates for revenue subject to customer rebates under the Honeywell Agreement increased operating income by $0.4 million ($0.3 million net of tax or $0.05 per diluted share). These changes in accounting estimates were the result of actual amounts billed and received differing from initial estimates.

Transaction costs incurred for this acquisition were $0.3 million and were included as part of the purchase price.

The assets acquired in connection with the acquisition were recorded by the Company at their estimated relative fair values as of the acquisition date as follows:

 

(In thousands)        

Inventory

  $1,411   $1,411 

Identifiable Intangible Assets

   22,162    27,243 
  

 

   

 

 

Total Purchase Price

  $23,573   $28,654 
  

 

   

 

 

The purchase price, including the initial payment, the minimum royalty payment obligation, transaction costs, and the transaction costs, wassubsequent TSA $0.4 million obligation payment, were allocated based on the relative fair value of the assets acquired. The fair value of the intangible assets acquired was estimated by applying the income approach. These fair value measurements are based on significant inputs that are not observable in the market and therefore represent a Level 3 measurement as defined in Accounting Standards Codification (ASC)ASC 820, “Fair Value Measurement and Disclosure.” Key assumptions in estimating the fair value of the intangibles include (1) the remaining life of the intangibles based on the term of the Honeywell Asset Purchase and License Agreement of 10 years, (2) a range of annual earnings projections from $3.9 million – $5.4 million and (3) the Company’s internal rate of return of 21.0%.

The acquired identifiable intangible assets are as follows:.

 

(In thousands)

  Fair Value   Useful Life
(Years)
   Fair
Value
   Useful Life
(Years)
 

Customer Contract Relationships

  $22,162    10   $27,243    10 
  

 

     

 

   

Trojan Label

On February 1, 2017, our newly-formed wholly-owned Danish subsidiary, ANI ApS, completed the acquisition of the issued and outstanding equity interests of TrojanLabel ApS (TrojanLabel), a Danish private limited liability company, pursuant to the terms of a Share Purchase Agreement dated January 7, 2017. Based in Copenhagen, Denmark, TrojanLabel is a manufacturer of products including digital color label presses and specialty printing systems for a broad range of end markets. Upon consummation of the acquisition, TrojanLabel became an indirect wholly-owned subsidiary of AstroNova.

The purchase price of this acquisition was 62.9 million Danish Krone (approximately $9.1 million), net of cash acquired of 976,000 Danish Krone (approximately $0.1 million), of which 6.4 million Danish Krone (approximately $0.9 million) was placed in escrow to secure certain post-closing working capital adjustments and indemnification obligations of the sellers. The acquisition was funded using available cashIn the first quarter of fiscal 2019, the Company settled the post-closing adjustments with TrojanLabel and investment securities.

The sellers of TrojanLabel may be entitled to additional contingent consideration if 80% of specified earnings targets are achieved by TrojanLabel during the seven years following the closing, subject to certain closing working capital adjustments and potential offsets to satisfy the sellers’ indemnification obligations. The contingent consideration consists of potentialearn-out payments to the sellers of between 32.5 millionrecovered approximately 891,000 Danish Krone (approximately $5.0 million) if 80%$145,000) of the specified earnings targets are achieved, 40.6 million Danish Krone (approximately $5.8 million) if 100% of the specified earnings targets are achieved, and a maximum of 48.7 million Danish Krone (approximately $7 million) if 120% of the specified earnings targets are achieved. The fair value of contingent consideration is re-evaluated each reporting period and charges are adjusted through earnings.

Total acquisition-related costs were approximately $0.7 million, ofamount held in escrow account, which $0.1 million and $0.6 million are included in the general and administrative expenses in the Company’s consolidated statements of income for the periods ending October 28, 2017 and January 31, 2017, respectively. The acquisition was accounted forrecognized as a purchase of a business under the acquisition method in accordance with the guidance provided by FASB ASC 805, “Business Combinations.”

The US dollar purchase price of the acquisition has been allocated on the basis of fair value as follows:

(In thousands)    

Accounts Receivable

  $1,322 

Inventory

   796 

Other Current Assets

   166 

Property, Plant and Equipment

   15 

Identifiable Intangible Assets

   3,264 

Goodwill

   7,388 

Accounts Payable and Other Current Liabilities

   (1,821

Other Liability

   (114

Contingent Liability (Earnout)

   (1,314

Deferred Tax Liability

   (695
  

 

 

 

Total Purchase Price

  $9,007 
  

 

 

 

The fair value of the intangible assets acquired was estimated by applying the income approach, and the fair value of the contingent consideration liability was estimated by applying the real options method. These fair value measurements are based on significant inputs that are not observable in the market and therefore represent a Level 3 measurement as defined in ASC 820, “Fair Value Measurement and Disclosure.” Key assumptions in estimating the fair value of the intangibles include (1) remaining life of existing technology acquired based on estimate of percentage of revenue from 0% – 100% for each product, (2) the Company’s internal rate of return of 19.0% and (3) a range of earnings projections from $121,000 – $1,070,000. Key assumptions in estimating the fair value of the contingent consideration liability include (1) the estimated earnout targets over the next seven years of $407,000–$1,280,000, (2) the probability of success (achievement of the various contingent events) from 1.6%–87.2% and (3) a risk-adjusted discount rate of approximately 1.77%–3.35% used to adjust the probability-weighted earnout payments to their present value. The fair value of the contingent liability will be revalued every reporting period based on updated assumptions. Refer to Note 17 “Fair Value” for further details.

Goodwill of $7.4 million, which is not deductible for tax purposes, represents the excess of the purchase price over the estimated fair value assignedan adjustment to the tangible and identifiable intangible assets acquired and liabilities assumed from TrojanLabel. The goodwill recognized is attributable to synergies which are expected to enhance and expand the Company’s overall product portfolio and opportunities in new and existing markets, future technologies that have yet to be determined and TrojanLabel’s assembled work force. The carrying amount of the goodwill was allocated to the Product Identification segment of the Company.

The following table reflects the fair value of the acquired identifiable intangible assets and related estimated useful lives:

(In thousands)

  Fair
Value
   Useful Life
(Years)
 

Existing Technology

  $2,327    7 

Non-Competition Agreement

   937    10 
  

 

 

   

Total

  $3,264   
  

 

 

   

The Existing Technology intangible asset acquired represents the various technologies TrojanLabel has developed related to its series of printing presses, including hardware components of the presses and the software utilized to optimize their performance.

Beginning February 1, 2017, the results of operationsallowance account for TrojanLabel have been included in the Company’s statement of income for the three and nine month periods ended October 28, 2017 and are reported as part of the Product Identification segment. Assuming the acquisition of TrojanLabel had occurred on February 1, 2016, the impact would not have had a material effect on the Company’s results for the three and nine month periods ended October 29, 2016.receivables. The remaining escrow balance was retained by TrojanLabel.

(5)(6) Net Income Per Common Share

Basic net income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of shares and, if dilutive, common equivalent shares, determined using the treasury stock method for stock options, restricted stock awards and restricted stock units outstanding during the period. A reconciliation of the shares used in calculating basic and diluted net income per share is as follows:

 

   Three Months Ended   Nine Months Ended 
   October 28,
2017
   October 29,
2016
   October 28,
2017
   October 29,
2016
 

Weighted Average Common Shares Outstanding— Basic

   6,725,414    7,444,478    6,968,285    7,406,977 

Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units

   95,507    149,750    109,601    164,705 
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted Average Common Shares Outstanding—Diluted

   6,820,921    7,594,228    7,077,886    7,571,682 
  

 

 

   

 

 

   

 

 

   

 

 

 
   Three Months Ended   Six Months Ended 
   July 28,
2018
   July 29,
2017
   July 28,
2018
   July 29,
2017
 

Weighted Average Common Shares Outstanding - Basic

   6,859,532    6,726,623    6,824,532    7,097,183 

Effect of Dilutive Options, Restricted Stock Awards and Restricted Stock Units

   222,976    111,213    174,946    121,238 
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted Average Common Shares Outstanding - Diluted

   7,082,508    6,837,836    6,999,478    7,218,421 
  

 

 

   

 

 

   

 

 

   

 

 

 

For the three and ninesix months ended OctoberJuly 28, 2018, the diluted per share amounts do not reflect common equivalent shares outstanding of 273,275 and 340,575, respectively. For the three and six months ended July 29, 2017, the diluted per share amounts do not reflect common equivalent shares outstanding of 609,934591,359 and 612591,309,248, respectively. For the three and nine months ended October 29, 2016 the diluted per share amounts do not reflect common equivalent shares outstanding of 406,187 and 460,667, respectively. These outstanding common equivalent shares were not included due to their anti-dilutive effect. Anti-dilutive shares consist of those common stock equivalents that have either an exercise price above the average stock price for the period or for which the common stock equivalent’s related average unrecognized stock compensation expense is sufficient to “buy back” the entire amount of shares. Restricted stock units which vest based upon achievement of performance targets are excluded from the diluted shares outstanding unless the performance targets have been met as of the end of the reporting period, regardless of whether such performance targets are probable of achievement as of the end of the measurement period.

(6)

(7) Intangible Assets

Intangible assets are as follows:

 

  October 28, 2017   January 31, 2017   July 28, 2018   January 31, 2018 
(In thousands)  Gross
Carrying
Amount
   Accumulated
Amortization
 Currency
Translation
Adjustment
   Net
Carrying
Amount
   Gross
Carrying
Amount
   Accumulated
Amortization
 Net
Carrying
Amount
   Gross
Carrying
Amount
 Accumulated
Amortization
 Currency
Translation
Adjustment
   Net
Carrying
Amount
   Gross
Carrying
Amount
   Accumulated
Amortization
 Currency
Translation
Adjustment
   Net
Carrying
Amount
 

Miltope:

                         

Customer Contract Relationships

  $3,100   $(1,356 $—     $1,744   $3,100   $(1,108 $1,992   $3,100  $(1,566 $—     $1,534   $3,100   $(1,438 $—     $1,662 

RITEC:

                         

Customer Contract Relationships

   2,830    (397  —      2,433    2,830    (207 2,623    2,830  (608  —      2,222    2,830    (461  —      2,369 

Non-Competition Agreement

   950    (443  —      507    950    (301 649    950  (586  —      364    950    (491  —      459 

TrojanLabel:

                         

Existing Technology

   2,327    (259 159    2,227    —      —     —      2,327  (535 174    1,966    2,327    (350 313    2,290 

Non-Competition Agreement

   937    (73 65    929    —      —     —   

Distributor Relations

   937  (151 70    856    937    (99 130    968 

Honeywell:

                         

Customer Contract Relationships

   22,162    (198  —      21,964    —      —     —      27,243 (2,397      24,846    26,843    (958  —      25,885 
  

 

   

 

  

 

   

 

   

 

   

 

  

 

   

 

  

 

  

 

   

 

   

 

   

 

  

 

   

 

 

Intangible Assets, net

  $32,306   $(2,726 224   $29,804   $6,880   $(1,616 $5,264   $37,387  $(5,843 $244   $31,788   $36,987   $(3,797 $443   $33,633 
  

 

   

 

  

 

   

 

   

 

   

 

  

 

   

 

  

 

  

 

   

 

   

 

   

 

  

 

   

 

 

*

Includes additional $0.4 million related to the payment in fiscal 2019 in accordance with the terms of the TSA.

There were no impairments to intangible assets during the three or nine month periods ended OctoberJuly 28, 20172018 and OctoberJuly 29, 2016.2017. With respect to the acquired intangibles included in the table above, amortization expense of $508,000$1,022,000 and $179,000$304,000 related to the above acquired intangibles has been included in the condensed consolidated statementsstatement of income for the three months ended OctoberJuly 28, 20172018 and OctoberJuly 29, 2016,2017, respectively. Amortization expense of $1,111,000$2,046,000 and $536,000$603,000 related to the above acquired intangibles has been included in the condensed consolidated statementsstatement of income for the ninesix months ended OctoberJuly 28, 2018 and July 29, 2017, and October 29, 2016, respectively.

Estimated amortization expense for the next five fiscal years is as follows:

(In thousands)  Remaining
2019
   2020   2021   2022   2023 

Estimated amortization expense

  $2,073   $4,234   $4,104   $4,017   $4,012 

(7)(8) Share-Based Compensation

We have one equity incentive plan pursuantAt the Company’s annual meeting of shareholders held on June 4, 2018, the Company’s shareholders approved the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards with respect to which we grant equityup to 650,000 shares of the Company’s common stock, plus an additional number of shares equal to the number of shares subject to awards granted under the 2018 Plan or the Company’s 2015 Equity Incentive Plan (the “2015 Plan”). Under this plan, and, together with the Company may grant incentive stock options,non-qualified stock options, stock appreciation rights, time or performance-based restricted stock units (RSUs), restricted stock awards (RSAs), and other stock-based awards to executives, key employees, directors and other eligible individuals. The 20152018 Plan, will expire in May 2025. Options granted to employees under the plan vest over four years and expire after ten years. The exercise price of each stock option is established at“Plans”) that are, following the discretioneffectiveness of the Compensation Committee; however, all options granted under the 20152018 Plan, must be issued at an exercise price of not less than the fair market value of the Company’s common stock on the date of grant. The 2015 Plan authorizesforfeited, cancelled, satisfied without the issuance of upstock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to 500,000 shares (subjectany unvested award, reacquired by the Company at not more than the grantee’s purchase price (other than by exercise). Following the approval of the 2018 Plan at the Company’s annual meeting of shareholders, the Company ceased granting new equity awards pursuant to adjustment for stock dividends and stock splits), and at October 28, 2017, 177,905 shares were available for grant under the 2015 Plan. In addition, as of October 28, 2017, 3,290 unvested shares of restricted stock granted and options to purchase an aggregate of 572,345 shares were outstanding under our 2007 Equity Incentive Plan (the “2007 Plan”). The 2007 Plan expired in May 2017 and no new awards may be issued under that plan, but outstanding awards will continue to be governed by it.

Under the 2015 Plan, eachnon-employee director receives an automatic annual grant often-year options to purchase 5,000 shares of stock upon the adjournment of each annual shareholders meeting. Each such option is exercisable at the fair market value of the Company’s common stock as of the grant date, and vests immediately prior to the next annual shareholders’ meeting.    Accordingly, on May 17, 2017, 30,000 options were issued to thenon-employee directors.

The Company has aNon-Employee Director Annual Compensation Program (the “Program”) under which eachnon-employee director receives an automatic grant of RSAsrestricted stock awards (“RSAs”) on the first business day of each fiscal quarter. Under the Program, the number of whole shares to be granted each quarter is equal to 25% of the number calculated by dividing the director compensation amount by the fair market value of the Company’s stock on such day. The director annual compensation amount was $55,000 in fiscal year 2017, is $65,000 in fiscal year 2018 and will beis $75,000 in fiscal year 2019. In addition, the Chairman of the Board receives RSAs with an aggregate value of $6,000, and the Chairs of the Audit and Compensation Committees each receive RSAs with an aggregate value of $4,000, also issued in quarterly installments and calculated in the same manner as the directors’ RSA grants. RSAs granted prior to March 30, 2017 becomebecame fully vested on the first anniversary of the date of grant. RSAs granted subsequent to March 30, 2017 become vested three months after the date of grant. A total of 7,3145,370 and 5,4957,314 shares were awarded to thenon-employee directors as compensation under the Program in the thirdsecond quarter of fiscal 2019 and 2018, and 2017, respectively.

In April 2013 (fiscal year 2014), the Company granted options and RSUs to officers (“2014 RSUs”). The 2014 RSUs vested as follows: twenty-five percent vested on the third anniversary of the grant date, fifty percent vested upon the Company achieving its cumulative budgeted net revenue target for fiscal years 2014 through 2016 (the “Measurement Period”), and twenty-five percent vested upon the Company achieving a target average annual ORONA (operating income return on net assets as calculated under the Domestic Management Bonus Plan) for the Measurement Period. The grantee may not sell, transfer or otherwise dispose of more than fifty percent of the common stock issued upon vesting of the 2014 RSUs until the first anniversary of the vesting date. In April 2016, 9,300 of the 2014 RSUs vested, as the Company achieved the targeted average annual ORONA, as defined in the plan, for the Measurement Period and another 9,300 vested as a result of the third year anniversary date of the grant. Additionally, on February 1, 2014, the Company accelerated the vesting of 4,166 of the 2014 RSUs held by Everett Pizzuti in connection with his retirement.

In March 2015 (fiscal year 2016), the Company granted 50,000 options and 537 RSAs to its CEOChief Executive Officer pursuant to the an Equity Incentive Award Agreement dated as of November 24, 2014 (“CEO Equity Incentive Agreement,Agreement”), and 35,000 options to other key employees.

In May 2015 (fiscal year 2016), the Company granted an aggregate of 80,000 time-based and 155,000 performance-based RSUs (“2016 RSUs”) to certain officers of the Company. The time-based 2016 RSUs vest in four equal annual installments commencing on the first anniversary of the grant date. The performance-based 2016 RSUs vest over three years based upon the increase in revenue, if any, achieved each fiscal year relative to a three-year revenue increase goal. Performance-based 2016 RSUs that are earned based on organic revenue growth are fully vested when earned, while those earned based on revenue growth via acquisitions vest annually over a three-year period following the fiscal year in which the revenue growth occurs. Any performance-based 2016 RSUs that havewere not been earned at the end of the three-year performance period will befiscal 2018 were forfeited. The expense for such shares iswas recognized in the fiscal year in which the results arewere achieved, however, the shares arewere not fully earned until approved by the Compensation Committee in the first quarter of the following fiscal year. Based upon revenue in fiscal 2018, 2017 and 2016, 33,638, 9,025 and 15,810 shares of the performance based RSUs were earned in the first quarter of fiscal 2019, 2018 and 2017, respectively.

In March 2016 (fiscal year 2017), the Company granted 50,000 options and 4,030 RSAs to its CEOChief Executive Officer pursuant to the CEO Equity Incentive Agreement.

In May 2016 (fiscal year 2017) the Company granted 37,000 options to certain key employees. On August 1, 2016 (fiscal year 2017) the Company granted 5,000 options to its Chief Financial Officer.

In March 2017 (fiscal year 2018), the Company granted 50,000 options to the Chief Executive Officer pursuant to the CEO Equity Incentive Agreement. In February and April 2017 (fiscal year 2018) the Company granted 52,189 options to certain other key employees.

The In December 2017, upon election to the Board, the Company granted 5,000non-qualified options and RSAs675 RSUs to a Board member. In January 2018, the Company granted March 2015 through March 2017 vest in four equal annual installments commencing on50,000non-qualified options and 15,000 RSUs to the first anniversarynewly appointed Chief Financial Officer.

In April 2018 (fiscal year 2019), the Company granted 5,000non-qualified options and 341 RSUs to a newly elected member of the grant date.Board of Directors.

In May 2018, the Company granted 40,000 options to certain key employees.

In June 2018, the Company granted an aggregate of 25,000non-qualified options to the members of the Board of Directors. Also in June 2018, the Company granted an aggregate of 126,000 options, 44,275 time-based RSUs and 38,000 performance-based RSUs to certain officers of the Company, all of which vest over three years. The number of performance-based RSUs that are eligible to vest will be determined based upon achievement of fiscal 2019 revenue and operating income targets.

Share-based compensation expense was recognized as follows:

 

  Three Months Ended   Nine Months Ended   Three Months Ended   Six Months Ended 
(In thousands)  October 28,
2017
   October 29,
2016
   October 28,
2017
   October 29,
2016
   July 28,
2018
   July 29,
2017
   July 28,
2018
   July 29,
2017
 

Stock Options

  $105   $85   $316   $253   $200   $117   $356   $211 

Restricted Stock Awards and Restricted Stock Units

   436    96    800    468    263    289    467    363 

Employee Stock Purchase Plan

   3    4    9    10    3    3    6    6 
  

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

 

Total

  $544   $185   $1,125   $731   $466   $409   $829   $580 
  

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

 

Stock Options

The fair value of stock options granted during the ninesix months ended OctoberJuly 28, 20172018 and OctoberJuly 29, 20162017 was estimated using the following weighted average assumptions:

 

  Nine Months Ended   Six Months Ended 
  October 28,
2017
 October 29,
2016
   July 28,
2018
 July 29,
2017
 

Risk Free Interest Rate

   1.7 1.4   2.6 1.7

Expected Volatility

   37.9 28.3   39.4 37.9

Expected Life (in years)

   8.0  5.0    9.0  8.0 

Expected Dividend Yield

   2.2 1.9

Dividend Yield

   1.5 2.0

There were no options granted during the three month periods ended October 28, 2017 and October 29, 2016. The weighted average fair value per share for options granted was $7.42 and $7.41 during the three and six month periods ended July 28, 2018, compared to $5.62 and $4.46 during the ninethree and six month periodperiods ended October 28, 2017, compared to $3.22 during the nine month period ended OctoberJuly 29, 2016.2017.

Aggregated information regarding stock options granted under the plansPlans for the ninesix months ended OctoberJuly 28, 2017,2018, is summarized below:

 

   Number of
Options
   Weighted Average
Exercise Price
 

Outstanding at January 31, 2017

   685,456   $11.96 

Granted

   132,189    13.45 

Exercised

   (66,550   10.60 

Forfeited

   (18,750   14.49 

Canceled

   (24,600   11.76 
  

 

 

   

 

 

 

Outstanding at October 28, 2017

   707,745   $12.31 
  

 

 

   

 

 

 

   Number of
Options
   Weighted
Average

Exercise Price
 

Outstanding at January 31, 2018

   745,270   $12.52 

Granted

   196,000    18.21 

Exercised

   (91,375   11.00 

Forfeited

   (850   13.98 

Canceled

   (3,700   8.95 
  

 

 

   

 

 

 

Outstanding at July 28, 2018

   845,345   $14.02 
  

 

 

   

 

 

 

Set forth below is a summary of options outstanding at OctoberJuly 28, 2017:2018:

 

Outstanding

   Exercisable 

Range of

Exercise prices

  Number
of
Shares
   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual Life
   Number
of
Shares
   Weighted-
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
 

$5.00-10.00

   171,631   $7.84    3.2    171,631   $7.84    3.2 

$10.01-15.00

   486,114   $13.61    7.7    261,325   $13.48    6.9 

$15.01-20.00

   50,000   $15.01    8.4    12,500   $15.01    8.3 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
   707,745   $12.31    6.6    445,456   $11.35    5.5 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
Outstanding  Exercisable 

Range of

Exercise prices

  Number of
Shares
  Weighted-
Average
Exercise
Price
  Weighted-
Average
Remaining
Contractual
Life
  Number of
Shares
   Weighted-
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
 
$5.00-10.00   106,331  $7.63   2.87   106,331   $7.63    2.87 
$10.01-15.00   493,014  $13.63   7.26   326,747   $13.60    6.62 
$15.01-20.00   246,000  $17.56   9.39   30,000   $15.17    7.98 
 

 

 

  

 

 

  

 

 

  

 

 

   

 

 

   

 

 

 
  845,345  $14.02   7.33   463,078   $12.33    5.84 
 

 

 

  

 

 

  

 

 

  

 

 

   

 

 

   

 

 

 

As of OctoberJuly 28, 2017,2018, there was approximately $694,000$2.0 million of unrecognized compensation expense related to stock options which is expected to be recognized over a weighted average period of approximately 2.42.7 years.

Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)

Aggregated information regarding RSUs and RSAs granted under the PlanPlans for the ninesix months ended OctoberJuly 28, 20172018 is summarized below:

 

  RSAs & RSUs   Weighted Average
Grant Date Fair Value
   RSAs & RSUs   Weighted Average
Grant Date
Fair Value
 

Unvested at January 31, 2017

   213,868   $14.08 

Unvested at January 31, 2018

  $177,347   $13.99 

Granted

   21,295    14.22    96,464    17.79 

Vested

   (49,935   14.36    (47,065   13.96 

Forfeited

   (9,087   14.05    (82,682   14.05 
  

 

   

 

   

 

   

 

 

Unvested at October 28, 2017

   176,141   $14.02 

Unvested at July 28, 2018

  $144,064   $16.52 
  

 

   

 

   

 

   

 

 

As of OctoberJuly 28, 2017,2018, there was approximately $481,000$1.4 million of unrecognized compensation expense related to RSUs and RSAs which is expected to be recognized over a weighted average period of 0.71.3 years.

Employee Stock Purchase Plan

AstroNova has an Employee Stock Purchase Plan allowing eligible employees to purchase shares of common stock at a 15% discount from fair value.value on the first or last day of an offering period, whichever is less. A total of 247,500 shares were reserved for issuance under this plan. During the ninesix months ended OctoberJuly 28, 20172018 and OctoberJuly 29, 2016,2017, there were 4,6572,342 and 4,7072,897 shares, respectively, purchased under this plan. At OctoberAs of July 28, 2017, 40,5672018, 36,865 shares remain available.

(8) Shareholders’ Equity

On May 1, 2017, the Company entered into a stock repurchase agreement to repurchase 826,305 shares of the Company’s common stock held by a trust established by Albert W. Ondis at a per share price of $13.60, for an aggregate repurchase price of $11.2 million. This stock repurchase was consummated on May 2, 2017 and was funded using existing cash on hand. Following this stock repurchase, the Ondis trust owns 36,000 shares of the Company’s common stock.

April L. Ondis, a director of the Company, is a beneficiary of the trust. The stock repurchase was authorized and approved by the Company’s Audit Committee as a related party transaction. Prior to entering into the agreement, the Company obtained an opinion from an independent investment banking firm that the consideration to be paid by the Company to the trust pursuant to the stock repurchase agreement would be fair to the public stockholders of the Company, other than the trust, from a financial point of view.

(9) Inventories

Inventories are stated at the lower of cost(first-in,first-out) and net realizable value and include material, labor and manufacturing overhead. The components of inventories are as follows:

 

(In thousands)  October 28, 2017   January 31, 2017   July 28,
2018
   January 31,
2018
 

Materials and Supplies

  $13,264   $11,865   $15,466   $13,715 

Work-In-Process

   1,475    1,216    1,425    1,404 

Finished Goods

   13,730    10,270    15,982    17,210 
  

 

   

 

   

 

   

 

 
   28,469    23,351    32,873    32,329 

Inventory Reserve

   (4,811   (3,845   (4,477   (4,720
  

 

   

 

   

 

   

 

 
  $23,658   $19,506   $28,396   $27,609 
  

 

   

 

   

 

   

 

 

(10) Income Taxes

The Company’s effective tax rates for the period which are based on the projected effective tax rate for the full year, are as follows:

 

  Three Months Ended Nine Months Ended   Three Months
Ended
 Six Months
Ended
 

Fiscal 2019

   27.8 24.1

Fiscal 2018

   12.4 17.9   24.1 23.4

Fiscal 2017

   35.1 31.5

The Company determines its estimated annual effective tax rate at the end of each interim period based on full-year forecastedpre-tax income and facts known at that time. The estimated annual effective tax rate is applied to theyear-to-datepre-tax income at the end of each interim period with the cumulative effect of any changes in the estimated annual effective tax rate being recorded in the fiscal quarter in which the change is determined. The tax effect of significant unusual items is reflected in the period in which they occur.

During the three months ended OctoberJuly 28, 2017,2018, the Company recognized an income tax expense of approximately $201,000.$459,000. The effective tax rate in this period was directly impacted by $334,000 of prior periodan $82,000 benefit arising from windfall tax benefits recognized uponrelated to the completion of an R&D study, partially offset by current tax increases from the mix of forecastedpre-tax earnings to higher taxing jurisdictions.Company’s stock. During the three months ended OctoberJuly 29, 2016, the Company recognized income tax expense of $623,000.

During the nine months ended October 28, 2017, the Company recognized an income tax expense of approximately 579,000.$231,000. The effective tax rate in this period was impacted by updated projected forecasted income and updated lower foreign tax rates for the Company’s foreign subsidiaries, as well as a $12,000 benefit arising from windfall tax benefits related to the Company’s stock.

During the six months ended July 28, 2018, the Company recognized an income tax expense of approximately $639,000. The effective tax rate in this period was directly impacted by $334,000 of prior perioda $112,000 tax benefit arising from windfall tax benefits recognized uponrelated to the completionCompany’s stock and a $78,000 tax benefit related to the expiration of an R&D study, partially offset by currentthe statute of limitations on a previously uncertain tax increases from the mix of forecastedpre-tax earnings to higher taxing jurisdictions.position . During the ninesix months ended OctoberJuly 29, 2016,2017, the Company recognized an income tax expense of $1,595,000approximately $378,000. The effective tax rate in this period was impacted by updated projected forecasted income and updated lower foreign tax rates for the Company’s foreign subsidiaries, as well as a $71,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position and a $27,000 benefit arising from windfall tax benefits related to the Company’s stock.

The Company maintains a valuation allowance on some of its deferred tax assets in certain jurisdictions. A valuation allowance is required when, based upon an assessment of various factors, including recent operating loss history, anticipated future earnings, and prudent and reasonable tax planning strategies, it is more likely than not that some portion of the deferred tax assets will not be realized.

Unrecognized tax benefits represent the difference between tax positions taken or expected to be taken in a tax return and the benefits recognized for financial reporting purposes. As of OctoberJuly 28, 2017,2018, the Company’s cumulative unrecognized tax benefits totaled $663,000$626,000 compared to $708,000$665,000 as of January 31, 2017.2018. During the first quarter, the Company was notified by the IRS that the fiscal 2015 and 2017 income tax returns were selected for audit. No adjustments have been raised at this time. There were no other developments affecting unrecognized tax benefits during the quarter ended OctoberJuly 28, 2017.2018.

On December��22, 2017, the President signed into law the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act significantly changes U.S. tax law by, among other things, lowering the U.S. corporate income tax rate from 35% to 21% effective January 1, 2018. As a result of the Tax Act, we wrote down our net deferred tax assets as of January 31, 2018 by $1.0 million to reflect the estimated impact of the Tax Act. Accordingly, we recorded a corresponding provisional netone-timenon-cash charge of $1.0 million, related tore-measurement of certain net deferred tax assets using the lower U.S. corporate income tax rate. We were capable of reasonably estimating the impact of the reduction to the U.S. Corporate tax rate on the deferred tax balances. However, the estimate may be affected by other aspects of the Tax Act.

The Tax Act taxes certain unrepatriated earnings and profits (“E&P”) of our foreign subsidiaries (the “Transition Tax”). In order to determine the Transition Tax, we must determine, along with other information, the amount of our accumulated post-1986 E&P for our foreign subsidiaries, as well as thenon-U.S. income tax paid by those subsidiaries on such E&P. We were capable of reasonably estimating theone-time deemed repatriation tax and recorded a provisional expense of $0.1 million at January 31, 2018.

ASC 740, “Income Taxes,” requires a company to record the effects of a tax law change in the period of enactment. ASU2018-05 allows a company to record a provisional amount when it does not have the necessary information available, prepared, or analyzed in reasonable detail to complete its accounting for the changes in the Tax Reform Act. The measurement period ends when the company has obtained, prepared and analyzed the information necessary to finalize its accounting, but cannot extend beyond one year from the date of enactment of the Tax Reform Act.

During the six months ended July 28, 2018, there were no changes made to the provisional amounts recognized in fiscal 2018. While we have substantially completed our provisional analysis of the income tax effects of the Tax Act and recorded a reasonable estimate of such effects, the netone-time charge related to the Tax Act may differ, possibly materially, due to, among other things, further refinement of our calculations, changes in interpretations and assumptions that we have made, additional guidance that may be issued by the U.S. Government, and actions and related accounting policy decisions we may take as a result of the Tax Act. We will complete our analysis over aone-year measurement period ending December 22, 2018, and any adjustments during this measurement period will be included in net earnings from continuing operations as an adjustment to income tax expense in the reporting period when such adjustments are determined.

The Tax Act also established a new law that affects fiscal 2019 and beyond, which includes, but is not limited to, (1) a reduction of the U.S. corporate income tax rate from 35% to 21%; (2) general elimination of U.S. federal income taxes on dividends from foreign subsidiaries; (3) a new limitation on the deduction of interest expense; (4) repeal of the domestic production activity deduction; (5) additional limitations on deduction of compensation for certain executives; (6) a new provision designed to tax global intangiblelow-taxed income (“GILTI”) which allows for the possibility of utilizing foreign tax credits (“FTCs”) and a deduction of up to 50% to offset the income tax liability (subject to certain limitations); (7) the

introduction of the base erosion anti-abuse tax which represents a new minimum tax; (8) limitations on utilization of FTCs to reduce U.S. income tax liability; (9) a new provision designed to provide a preferential tax rate for income derived by domestic corporations from servicing foreign markets (“FDII”) and (10) limitations on net operating losses (“NOLs”) generated after December 31, 2017 to 80% of taxable income.

(11) Revolving Credit FacilityAgreement

On February 28, 2017, the Company and it’sits wholly owned Danish subsidiaries, ANI ApS and TrojanLabel ApS (together, with the Company, ANI ApS and TrojanLabel Aps, the “Parties”), entered into a Credit Agreement with Bank of America, N.A. (the “Lender”). The Credit Agreement providesprovided for a term loan to ANI ApS in the principal amount of $9.2 million. The Credit Agreement also provided for a $10.0 million revolving credit facility available to the Company for general corporate purposes. Revolving credit loans may be borrowed, at the Company’s option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Krone. Upon entry into the Credit Agreement, the Company’s prior credit facility with Wells Fargo Bank was terminated. No loans or other amounts were outstanding or owed under that facility at the time of termination.

The Company is required to pay a commitment fee on the undrawn portion of the revolving credit facility at the rate of 0.25% per annum.

In connection with the Honeywell Purchase and License Agreement, on September 28, 2017, the Parties entered into a First Amendment to the Credit Agreement with the Lender. The First Amendment amended the existing Credit Agreement to permit the Honeywell Asset Purchase and License Agreement and temporarily increased the amount available for borrowing under the revolving credit facility from $10.0 million to $15.0 million.

The initial upfront payment of $14.6 million for the Honeywell Agreement was paid using borrowings under the Company’s revolving credit facility. Interest on this revolving credit facility accrued at a rate of 4.25%per annum on the outstanding borrowings and is due and payable on the last day of each of the Company’s fiscal quarters. As of October 28, 2017, the Company has accrued $51,000 of interest for this revolving credit facility, which is included in Other Liabilities and Accrued Expenses on the accompanying condensed consolidated balance sheet at October 28, 2017.

As of October 28, 2017, $400,000 of the revolving credit facility remains available under the amended Credit Agreement.

Subsequent to the fiscal quarter end, onOn November 30, 2017, the CompanyParties entered into a Second Amendment to the Credit Agreement with the Lender. The Second Amendment providesprovided for a term loan to the Company in the principal amount of $15.0 million, in addition to the revolving credit facility for the Company and the term loan previously borrowed by ANI ApS at the original closing under the Credit Agreement. The Company borrowed the entire $15.0 million ofproceeds from the term loan upon the closing of the Second Amendment on November 30, 2017 andwere used the proceeds to repay the entire $14.6 million principal balance of the revolving loanloans outstanding under the revolving credit facility as of October 28, 2017. In accordance with the scheduled principal payments commencing January 2018 for the $15.0 million term loan, the Company has classified $2.25 million of the revolving credit facility as a current liability on the accompanying condensed consolidated balance sheet at October 28, 2017.

facility. The principal amount of the revolving credit facility under the Credit Agreement, which had been temporarily increased to $15.0 million pursuant to the First Amendment, was reduced to $10.0 million effective upon the closing of the Second Amendment and the maturity date for the revolving credit facility termination and maturity date was extended from January 31, 2022 to November 22,30, 2022. Refer to Note 19, “Subsequent Event” for further details.

(12) Debt

Long-term debt in the accompanying condensed consolidated balance sheets is as follows:

(In thousands)

  October 28, 2017   January 31, 2017 

USD Term Loan with a rate equal to LIBOR plus a margin of 1.0% to 1.5%, (1.78% as of October 28, 2017), and maturity date of January 31, 2022

  $8,648   $—   

Less:

    

Debt Issuance Costs, net of accumulated amortization

  $(147  $—   

Current Portion of Term Loan

  $(1,656  $—   
  

 

 

   

 

 

 

Long-Term Debt

  $6,845   $—   
  

 

 

   

 

 

 

The schedule of required principal payments remaining during the next five years on long-term debt outstanding as of October 28, 2017 is as follows:

(In thousands)    

Fiscal 2018

  $552 

Fiscal 2019

   1,472 

Fiscal 2020

   1,840 

Fiscal 2021

   2,208 

Fiscal 2022

   2,576 
  

 

 

 
  $8,648 
  

 

 

 

On February 28, 2017,April 17, 2018, the Parties entered into a Third Amendment to the Credit Agreement with the Lender. The Parties also entered intoThird Amendment provides that no “Immaterial Subsidiary” will be required to become a related Securityguarantor or securing party under (unless requested by the Lender during default) or have its equity pledged pursuant to the Credit Agreement. The Third Amendment defines “Immaterial Subsidiary” as any subsidiary of the Company with (a) consolidated total assets that do not exceed 5.0% of the consolidated total assets of the Company and Pledge Agreement withits subsidiaries and (b) revenues that do not exceed 5.0% of the Lender. The Credit Agreement providesconsolidated revenues of the Company and its subsidiaries, as of the last day of the most recent fiscal quarter; provided that Immaterial Subsidiaries shall not account for, a term loan to ANI ApS in the amountaggregate, more than 10% the of $9.2 million.consolidated total assets or consolidated revenues of the Company and its subsidiaries.

The term loan bears interest underIn connection with the Credit Agreement, at a rateper annum equalAstroNova and ANI ApS entered into certain hedging arrangements with the Lender to manage the LIBORvariable interest rate plus a margin that varies within a rangerisk and currency risk associated with its payments in respect of 1.0%the term loans. Refer to 1.5% based onNote 13, “Derivative Financial Instruments and Risk Management” for further information about these arrangements.

Revolving credit loans may be borrowed, at the Company’s consolidated leverage ratio.option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Krone. Amounts borrowed under the revolving credit facility bear interest at a rate per annum equal to, at the Company’s option, either (a) the LIBOR rate (or in the case of revolving credit loans denominated in a currency other than U.S. Dollars, the applicable quoted rate), plus a margin that varies within a range of 1.0% to 1.5% based on the Company’s consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal funds’ rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate or (iii) the LIBOR rate plus 1.00%, plus a margin that varies within a range of 0.0% to 0.5% based on the Company’s consolidated leverage ratio.

In connection with The Company is required to pay a commitment fee on the Credit Agreement, AstroNova and ANI ApS entered into certain hedging arrangements with the Lender to manage the variable interest rate risk and currency risk associated with its payments in respectundrawn portion of the term loan. Refer to Note 13, “Derivative Financial Instruments and Risk Management” for further information about these arrangements.revolving credit facility at the rate of 0.25% per annum.

The Parties must comply with various customary financial andnon-financial covenants under the Credit Agreement. The financial covenants consist of a maximum consolidated leverage ratio and a minimum consolidated fixed charge coverage ratio. The Credit Agreement contains limitations, in each case subject to various exceptions and thresholds, on the Company’s and its subsidiaries’ ability to incur future indebtedness, to place liens on assets, to conduct mergers or acquisitions, to sell assets, to alter their capital structure, to make investments and loans, to change the nature of their business, and to prepay subordinated indebtedness. The Credit Agreement permits the Company to pay cash dividends on and repurchase shares of its common stock, subject to certain limitations.

In connection The Company believes it is in compliance with all of the May 1, 2017 stock repurchase (refer to Note 8, “Shareholders’ Equity”), the Parties entered into a consent and amendment with the Lender, dated as of May 1, 2017, relating tocovenants in the Credit Agreement solely for purposesas of effecting the stock repurchase. The amendment increased the aggregate amount of certain repurchases of Company equity interests permitted to be made by the Company under the Credit Agreement in the Company’s fiscal year ending January 31, 2018, from $5,000,000 to $12,000,000, subject to certain conditions. The amendment prohibits the Company from making other repurchases of Company equity interests under such permission in the fiscal year ending January 31,July 28, 2018. The amendment also provides that the aggregate amount paid in cash by the Company to effect the stock repurchase shall not be deducted from the Company’s consolidated EBITDA for the purposes of calculating the consolidated fixed charge coverage ratio covenant to which the Company is subject under the Credit Agreement with respect to any trailing four-fiscal-quarter measurement period through and including the measurement period ending January 31, 2018.

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit commitment under the Credit Agreement upon the occurrence of any of various customary events of default, which include, among other events, the following: failure to pay when due any principal, interest or other amounts in respect of the loans, breach of any of the Company’s covenants or representations under the loan documents, default under any other of the Company’s or its subsidiaries’ significant indebtedness agreements, a bankruptcy, insolvency or similar event with respect to the Company or any of its subsidiaries, a significant unsatisfied judgment against the Company or any of its subsidiaries, or a change of control of the Company.

The obligations of ANI ApS in respect of the $9.2 million term loan are guaranteed by the Company and TrojanLabel. The Company’s obligations in respect of the $15.0 million term loan, revolving credit facility and its guarantee in respect of the ANI ApS term loan are secured by substantially all of the assets of the Company (including a pledge of a portion of the equity interests held by the Company in ANI ApS and the Company’s wholly-owned German subsidiaryAstro-Med GmbH), subject to certain exceptions.

In the second quarter of the current year, $3.0 million was drawn on the revolving credit facility, of which $1.5 million was repaid during the quarter and $1.5 million remained outstanding as of July 28, 2018. The outstanding balance bears interest at an annual rate of 5.5% and $17.5 thousand of interest has been accrued on this obligation and included in other expense in the accompanying condensed consolidated income statement for the three and six months ended July 28, 2018. As of OctoberJuly 28, 2017, we believe2018, there is $8.5 million available for borrowing under the Company is in compliance with all of the covenantsrevolving credit facility.

(12) Debt

Long-term debt in the Credit Agreement.accompanying condensed consolidated balance sheets is as follows:

Subsequent to

(In thousands)  July 28,
2018
   January 31,
2018
 

USD Term Loan with a rate equal to LIBOR plus a margin of 1.0% to 1.5%, (3.38% as of July 28, 2018 and 2.85% as of January 31, 2018), and maturity date of November 30, 2022

  $12,750   $15,000 

USD Term Loan with a rate equal to LIBOR plus a margin of 1.0% to 1.5%, (3.38% as of July 28, 2018 and 3.06% as of January 31, 2018), and maturity date of January 31, 2022

   7,714    8,372 
  

 

 

   

 

 

 
   20,464    23,372 

Debt Issuance Costs, net of accumulated amortization

   (191   (226

Current Portion of Term Loan

   (5,024   (5,498
  

 

 

   

 

 

 

Long-Term Debt

  $15,249   $17,648 
  

 

 

   

 

 

 

The schedule of required principal payments remaining during the fiscal quarter end, the Company entered into a Second Amendment to the Credit Agreement with Banknext five years on long-term debt outstanding as of America, N.A., on November 30, 2017. The Second Amendment provides for a term loan to the Company in the principal amount of $15.0 million. Refer to Note 19, “Subsequent Event” for further details.July 28, 2018 is as follows:

(In thousands)    

Fiscal 2019 (remaining)

  $2,590 

Fiscal 2020

   4,840 

Fiscal 2021

   5,208 

Fiscal 2022

   5,576 

Fiscal 2023

   2,250 
  

 

 

 
  $20,464 
  

 

 

 

(13) Derivative Financial Instruments and Risk Management

As a multinational enterprise, AstroNova is exposed to certain risks relating to our ongoing business operations. We employ a number of practices to manage these risks, including operating and financing activities, and where appropriate, the use of derivative instruments. The primary risks managed by using derivative instruments are interest rate risk and foreign currency exchange rate risk.

ASC 815, “Derivatives and Hedging,” requires the Company to recognize all of its derivative instruments as either assets or liabilities in the statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation. For derivative instruments not designated as hedging instruments, the gain or loss is recognized in the statement of income during the current period.

For derivative instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income (OCI) and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings (e.g., in “interest expense” when the hedged transactions are interest cash flows associated with floating-rate debt, or “other income (expense)” for portions reclassified relating to the remeasurement of the debt). The remaining gain or loss on the derivative instrument in excess of the cumulative change in the present value of future cash flows of the hedged item, if any (i.e., the ineffectiveness portion), or hedge components excluded from the assessment of effectiveness, are recognized in the statement of financial income during the current period.

In connection with the Credit Agreement, we entered into a cross-currency interest rate swap to manage the interest rate risk and foreign currency exchange risk associated with the floating-rate foreign currency-denominated term loan borrowing by our Danish Subsidiary and inan interest rate swap to manage the interest rate risk associated with the variable rate $15.0 million term loan borrowing by the Company. In accordance with the guidance in ASC 815 “Derivatives and Hedging”, both swaps have been designated this swap as a cash flow hedgehedges of floating-rate borrowings.

The cross-currency interest rate swap agreement utilized by the Company effectively modifies the Company’s exposure to interest rate risk and foreign currency exchange rate risk by converting approximately $8.9 million of the Company’s floating-rate debt denominated in U.S. Dollars on our Danish subsidiary’s books to a fixed-rate debt denominated in Danish Krone for the next five years,term of the loan, thus reducing the impact of interest-rate and foreign currency exchange rate changes on future interest expense and principal repayments. This swap involves the receipt of floating rate amounts in U.S. Dollars in exchange for fixed-rate interest payments in Danish Krone, as well as exchanges of principal at the inception spot rate, over the life of the Credit Agreement.

Subsequent to the fiscal quarter end, on November 30, 2017, the Parties entered into a Second Amendment to the Credit Agreement with Bank of America, N.A. which provides for a term loan to the Company in the principal amount of $15.0 million. In connection with this, the Company entered into certain hedging arrangements with Bank of America to manage the variable interest rate risk associated with its payments in respect to the $15.0 million term loan.

As of OctoberJuly 28, 2017,2018, the total notional amount of the Company’s cross-currency interest rate swap was $8.1 million;$7.1 million and is included in other long term liabilities in the Company’s condensed consolidated balance sheet at its fair value amount of $0.8 million.

The interest rate swap agreement utilized by the Company on the $15.0 million term loan effectively modifies the Company’s exposure to interest rate risk by converting the Company’s floating-rate debt to fixed-rate debt for the next five years, thus reducing the impact of interest-rate changes on future interest expense. This swap involves the receipt of floating rate amounts in U.S. Dollars in exchange for fixed rate payments in U.S. dollars over the life of the term loan. As of July 28, 2018, the total notional amount of the Company’s interest rate swap was $0.9$12.8 million and is included in other assets in the Company’s condensed consolidated balance at its fair value amount of $0.2 million.

The following tables present the impact of the derivative instrumentinstruments in our condensed consolidated financial statements for the three and ninesix months ended OctoberJuly 28, 20172018 and OctoberJuly 29, 2016:2017:

 

  Three Months Ended   Three Months Ended 
  Amount of Gain
(Loss)
Recognized in OCI
on
Derivative
(Effective Portion)
   Location of Gain (Loss)
Reclassified from
Accumulated OCI into
Income (Effective Portion)
 Amount of Gain (Loss)
Reclassified from
Accumulated OCI into
Income (Effective Portion)
   Amount of Gain (Loss)
Recognized in OCI
on Derivative
  Location of
Gain (Loss)
Reclassified
from Accumulated
OCI into
Income
 Amount of Gain (Loss)
Reclassified from
Accumulated OCI
into Income
 

Cash Flow Hedge

(In thousands)

  October 28,
2017
   October 29,
2016
    October 28,
2017
   October 29,
2016
   July 28,
2018
   July 29,
2017
 July 28,
2018
   July 29,
2017
 

Swap contract

  $137   $—     Other Income (Expense) $134   $—   

Swap contracts

  $315   $(643 Other Income (Expense) $327   $(633
  

 

   

 

    

 

   

 

   

 

   

 

   

 

   

 

 

 

  Nine Months Ended   Six Months Ended 
  Amount of Gain
(Loss)
Recognized in OCI
on
Derivative
(Effective Portion)
   Location of Gain (Loss)
Reclassified from
Accumulated OCI into
Income (Effective Portion)
 Amount of Gain (Loss)
Reclassified from
Accumulated OCI into
Income (Effective Portion)
   Amount of Gain (Loss)
Recognized in OCI
on Derivative
  Location of
Gain (Loss)
Reclassified
from Accumulated
OCI into Income
(Effective Portion)
 Amount of Gain (Loss)
Reclassified from
Accumulated OCI
into Income
 

Cash Flow Hedge

(In thousands)

  October 28,
2017
 October 29,
2016
    October 28,
2017
 October 29,
2016
   July 28,
2018
   July 29,
2017
 July 28,
2018
   July 29,
2017
 

Swap contract

  $(898 $—     Other Income (Expense) $(819 $—   

Swap contracts

  $698   $(1,035 Other Income (Expense) $583   $(953)
  

 

  

 

    

 

  

 

   

 

   

 

   

 

   

 

 

The swap contract resulted in no ineffectiveness for the three and nine months ended OctoberAt July 28, 2017, and no gains or losses were reclassified into earnings as a result of the discontinuance of the swap contract due to the original forecasted transaction no longer being probable of occurring. At October 28, 2017,2018, the Company expects to reclassify approximately $66,000$0.3 million of net gains on the swap contractcontracts from accumulated other comprehensive income (loss) to earnings during the next 12 months due to changes in foreign exchange rates and the payment of variable interest associated with the floating-rate debt.

(14) Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss by component are as follows:

(In thousands)

  Foreign
Currency
Translation
Adjustments
   Unrealized
Holding
Gain/(Loss)
on Available
for Sale
Securities
   Net
Unrealized
Gain/(Loss)
on Cash
Flow
Hedges
   Total 

Balance at January 31, 2018

  $(178  $(6  $12   $(172

Other Comprehensive Income (Loss) before reclassification

   (618   —      545    (73

Amounts reclassified from AOCI to Earnings

   —      3    (455   (452
  

 

 

   

 

 

   

 

 

   

 

 

 

Other Comprehensive Income (Loss)

   (618   3    90    (525
  

 

 

   

 

 

   

 

 

   

 

 

 

Balance at July 28, 2018

  $(796  $(3  $102   $(697
  

 

 

   

 

 

   

 

 

   

 

 

 

The amounts presented above in other comprehensive loss are net of taxes except for translation adjustments associated with our German and Danish subsidiaries.

(15) Segment Information

AstroNova reports two segments: Product Identification and Test & Measurement (T&M). The Company evaluates segment performance based on the segment profit before corporate expenses.

Summarized below are the Revenue and Segment Operating Profit for each reporting segment:

 

   Three Months Ended  Nine Months Ended 
   Revenue   Segment Operating Profit  Revenue   Segment Operating Profit 

(In thousands)

  October 28,
2017
   October 29,
2016
   October 28,
2017
  October 29,
2016
  October 28,
2017
   October 29,
2016
   October 28,
2017
  October 29,
2016
 

Product Identification

  $20,458   $16,892   $2,657  $2,443  $59,945   $51,126   $7,761  $7,069 

T&M

   8,302    6,450    1,572   1,282   20,756    21,665    2,300   3,625 
  

 

 

   

 

 

   

 

 

  

 

 

  

 

 

   

 

 

   

 

 

  

 

 

 

Total

  $28,760   $23,342    4,229   3,725  $80,701   $72,791    10,061   10,694 
  

 

 

   

 

 

     

 

 

   

 

 

    

Corporate Expenses

       2,597   1,891       6,780   5,566 
      

 

 

  

 

 

      

 

 

  

 

 

 

Operating Income

       1,632   1,834       3,281   5,128 

Other Expense, Net

       (12  (60      (45  (72
      

 

 

  

 

 

      

 

 

  

 

 

 

Income Before Income Taxes

       1,620   1,774       3,236   5,056 

Income Tax Provision

       201   623       579   1,595 
      

 

 

  

 

 

      

 

 

  

 

 

 

Net Income

      $1,419  $1,151      $2,657  $3,461 
      

 

 

  

 

 

      

 

 

  

 

 

 

   Three Months Ended   Six Months Ended 
   Revenue   Segment Operating Profit   Revenue   Segment Operating Profit 

(In thousands)

  July 28,
2018
   July 29,
2017
   July 28,
2018
  July 29,
2017
   July 28,
2018
   July 29,
2017
   July 28,
2018
  July 29,
2017
 

Product Identification

  $21,769   $20,841   $2,159  $2,612   $41,722   $39,487   $3,820  $5,104 

T&M

   12,038    6,642    2,814   657    23,572    12,454    5,071   728 
  

 

 

   

 

 

   

 

 

  

 

 

   

 

 

   

 

 

   

 

 

  

 

 

 

Total

  $33,807   $27,483    4,973   3,269   $65,294   $51,941    8,891   5,832 
  

 

 

   

 

 

      

 

 

   

 

 

    

Corporate Expenses

       2,808   2,327        5,462   4,183 
      

 

 

  

 

 

       

 

 

  

 

 

 

Operating Income

       2,165   942        3,429   1,649 

Other Income (Expense), Net

       (512  16        (782  (33
      

 

 

  

 

 

       

 

 

  

 

 

 

Income Before Income Taxes

       1,653   958        2,647   1,616 

Income Tax Provision

       459   231        639   378 
      

 

 

  

 

 

       

 

 

  

 

 

 

Net Income

      $1,194  $727       $2,008  $1,238 
      

 

 

  

 

 

       

 

 

  

 

 

 

(15)(16) Recent Accounting Pronouncements

Derivatives and HedgingRecently Adopted Accounting Pronouncements

Share-Based Compensation

In August 2017,June 2018, the Financial Accounting Standards Board (FASB)(“FASB”) issued ASUAccounting Standards Update (“ASU”)2017-12,2018-07 “Derivatives and Hedging: Targeted“Compensation—Stock Compensation (Topic 718): Improvements to Accounting for Hedging Activities.Nonemployee Share-Based Payment Accounting.The objective of this new guidance is to improveASU2018-07 reduces the cost and complexity and improves financial reporting by expanding the scope of hedging relationships by, among other things, eliminating the requirementTopic 718 to separately measure and record hedge ineffectiveness.include share-based payment transactions to nonemployees. ASU2017-122018-07 is effective for public companies for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early application is permitted using a modified retrospective methodyears with early adoption permitted. We adopted the provisions of this guidance effective asbeginning in the second quarter of the beginning of the fiscalcurrent year. The Company is still evaluating the impactadoption of adopting this guidance but doesdid not believe it will have a material impact on the Company’s consolidated financial statements.

GoodwillIncome Taxes

In January 2017,March 2018, the FASB issued ASU2017-04,2018-05—“Income Taxes “Intangibles—Goodwill and Other (Topic 350).740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting BulletinNo. 118.” ASU2017-14 2018-05 provides simplifiesguidance for companies related to the subsequentU.S. government-enacted comprehensive tax legislation commonly referred to as the Tax Act.ASU 2018-05 allows for a measurement period of goodwill impairment. The new guidance eliminatesup to one year after thetwo-step process that required identification of potential impairment and a separate measure enactment date of the actual impairment. Goodwill impairment charges, if any, would be determined by reducingTax Act to finalize the goodwill balance byrecording of the difference between the carrying value and the reporting unit’s fair value (impairment loss is limited to the carrying value).related tax impacts. This standardASU is effective for annual or any interim goodwill impairment tests beginning after December 15, 2019.immediately as new information is available to adjust provisional amounts that were previously recorded. The Company does not believeadopted this standard in the adoptionfirst quarter of this guidance will have a material impact onfiscal 2019 and expects the Company’s consolidated financial statements.accounting for the tax effects of the Tax Act to be completed during the measurement period.

Business CombinationsComprehensive Income

In January 2017,February 2018, the FASB issued ASU2017-01, “Business2018-02, Combinations“Income Statement-Reporting Comprehensive Income (Topic 805)220): ClarifyingReclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” ASU2018-02 amends ASU Topic 220 and allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Definition of a Business,which clarifiesTax Act, to eliminate the definition of a business to assist entities with determining whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The standard introduces a screen for determining when assets acquired are not a business (if substantially all ofstranded tax effects resulting from the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, then underTax Act. This ASU2017-01, the asset or group of assets is not a business) and clarifies that a business must include, at a minimum, an input and a substantive process that contribute to an output to be considered a business. This standard is effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted in certain circumstances. The Company has elected to early adopt ASU2017-101 as a result of the Honeywell acquisition and has accounted for this transaction as a purchase of an asset in its condensed consolidated financial statements for the period ending October 28, 2017.

Statement of Cash Flows

In August 2016, the FASB issued ASU2016-15, “Classification of Certain Cash Receipts and Cash Payments (Topic 230).” ASU2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice for certain cash receipts and cash payments. The standard is effective for annual reporting periods beginning after December 15, 2017 and interim periods within those years (Q1 fiscal 2019 for AstroNova),2018 with early adoption permitted. The amendments in this update should be applied either in the period of adoption or retrospectively to each period (or periods) in which the effect of the change in the U.S. federal corporate income tax rate in the Tax Cuts and Jobs Act is recognized. The Company does not believeearly adopted this amendment in the adoptionsecond quarter of this guidance will have a material impact on the Company’s consolidated financial statements.fiscal 2019 and reclassified $14,000 from accumulated other comprehensive income to retained earnings.

Revenue Recognition

In May 2014, the FASB issued ASU2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU2014-09 completes the joint effort by the FASB and International Accounting Standards Board to improve financial reporting by creating common revenue recognition guidance for U.S. GAAP and International Financial Reporting Standards. ASU2014-09 applies to all companies that enter into contracts with customers to transfer goods or services. Under this guidance, revenue is recognized when a customer obtains control of promised goods or services in an amount that reflects the consideration the entity expects to receive in exchange for those goods or services. In August 2015,addition, the FASBstandard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The Company adopted this guidance effective February 1, 2018 using the modified ASU2014-09 to be effective for annual reporting periods beginning after December 15, 2017 (Q1 fiscal 2019 for AstroNova), including interim periods within that reporting period. As modified, the FASB permits theretrospective method. The adoption of the new revenue standard early, but not before annual periods beginning after December 15, 2016. Entities have the choice to apply ASU2014-09 either retrospectively to each reporting period presented or by recognizing the cumulative effect of applying ASU2014-09 at the date of initial application and not adjusting comparative information.

In March 2016, the FASB issued ASU2016-08, “Revenue from Contracts with Customers (Topic 606)—Principal versus Agent Consideration.” In April 2016, the FASB issued ASU2016-10, “Revenue from Contracts with Customers (Topic 606)—Identifying Performance Obligations and Licensing.” In May 2016, the FASB issued ASU2016-11, “Revenue from Contracts with Customers (Topic 606) and Derivatives and Hedging (Topic 815)—Rescission of SEC Guidance Because of ASU2014-09 and2014-16” and ASU2016-12, “Revenue from Contracts with Customers (Topic 606)—Narrow Scope Improvements and Practical Expedients.” All of these ASUs do not change the core principle of the guidance in Topic 606 (as amended by ASU2014-09), but rather provide further guidance to improve the operability and understandability of the implementation guidance included in ASU2014-09. The effective date for all of these ASUs is the same as the effective date of ASU2014-09 as amended by ASU2015-14, for annual reporting periods beginning after December 15, 2017, including interim periods within those years (Q1 fiscal 2019 for AstroNova). The Company is currently evaluating the impact and method of adopting this guidance and while we dodid not expect that the adoption of these ASUs will have a material impact on the Company’s consolidated financial statements, we do expectstatements. Refer to Note 4, “Revenue Recognition” for further details.

Derivatives and Hedging

In August 2017, the adoptionFASB issued ASU2017-12, “Derivatives and Hedging: Targeted Improvements to result in a change in timingAccounting for Hedging Activities.” The objective of recognizing expense for commission earned on the sales of extended service contracts. The Company has not yet decided on the method of adoption to be applied when this new guidance becomes effective.is to improve the financial reporting of hedging relationships by, among other things, eliminating the requirement to separately measure and record hedge ineffectiveness. ASU2017-12 is effective for public companies for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years with early adoption permitted. We adopted the provisions of this guidance effective for the first quarter of fiscal 2019. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Share-Based Compensation

In May 2017, the FASB issued ASU2017-09 “Stock Compensation: Scope of Modification Accounting.” ASU2017-09 provides guidance on the types of changes to the terms or conditions of share-based payment awards to which an entity would be required to apply modification accounting under ASC 718. The Company adopted this guidance effective February 1, 2018. The adoption of this guidance did not have a material impact on its consolidated financial statements.

Statement of Cash Flows

In August 2016, the FASB issued ASU2016-15, “Classification of Certain Cash Receipts and Cash Payments (Topic 230).” ASU2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice for certain cash receipts and cash payments. The Company adopted this guidance affective February 1, 2018. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Recent Accounting Pronouncements Not Yet Adopted

Leases

In February 2016, the FASB issued ASU2016-02, “Leases (Topic 842).” ASU2016-02 supersedes current guidance related to accounting for leases and is intended to increase transparency and comparability among organizations by requiring lessees to recognize assets and liabilities in the balance sheet for operating leases with lease terms greater than twelve months. The update also requires improved disclosures to help users of financial statements better understand the amount, timing and uncertainty of cash flows arising from leases. In July 2018, the FASB issued ASU2018-11, “Leases (Topic 842) Targeted Improvements,” which amends ASU2016-02 to provide an additional (and optional) transition method to adopt the new lease standard. These ASUs will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years (Q1 fiscal 2020 for AstroNova), with early adoption permitted. At adoption, this update will be applied using a modified retrospective approach. The Company is currently evaluating the effect of this new guidance and expects this guidance to result in recognizing leased assets and lease liabilities on the Company’sour consolidated financial statements.balance sheets.

No other new accounting pronouncements, issued or effective during the first ninesix months of the current year, have had or are expected to have a material impact on our consolidated financial statements.

(16) Securities Available for Sale

Pursuant to our investment policy, securities available for sale include state and municipal securities with various contractual or anticipated maturity dates ranging from 1 to 16 months. Securities available for sale are carried at fair value, with unrealized gains and losses reported as a component of accumulated other comprehensive income (loss) in shareholders’ equity until realized. Realized gains and losses from the sale ofavailable-for-sale securities, if any, are determined on a specific identification basis. A decline in the fair value of anyavailable-for-sale security below cost that is determined to be other than temporary will result in a write-down of its carrying amount to fair value. No such impairment charges were recorded for any period presented. All short-term investment securities have original maturities greater than 90 days.

The fair value, amortized cost and gross unrealized gains and losses of securities available for sale are as follows:

(In thousands)

October 28, 2017

  Amortized Cost   Gross Unrealized
Gains
   Gross Unrealized
Losses
   Fair Value 

State and Municipal Obligations

  $3,286   $—     $(2  $3,284 
  

 

 

   

 

 

   

 

 

   

 

 

 

January 31, 2017

  Amortized Cost   Gross Unrealized
Gains
   Gross Unrealized
Losses
   Fair Value 

State and Municipal Obligations

  $6,732   $—     $(9  $6,723 
  

 

 

   

 

 

   

 

 

   

 

 

 

(17) Fair Value

We measure our financial and nonfinancial assets at fair value on a recurring basis in accordance with the guidance provided in ASC 820, “Fair Value Measurement and Disclosures” which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). In addition, ASC 820 establishes a three-tiered hierarchy for inputs used in management’s determination of fair value of financial instruments that emphasizes the use of observable inputs over the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that reflect management’s belief about the assumptions market participants would use in pricing a financial instrument based on the best information available in the circumstances.

The fair value hierarchy is summarized as follows:

Level 1—Quoted prices in active markets for identical assets or liabilities;

Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Cash and cash equivalents, accounts receivable, accounts payable, line of credit receivable, accrued compensation, other liabilities and accrued expenses and income tax payable are reflected in the condensed consolidated balance sheet at carrying value, which approximates fair value due to the short term nature of the these instruments.

Assets and Liabilities Recorded at Fair Value on a Recurring Basis

Fair value is applied to our financial assets and liabilities including money market funds, available for sale securities, derivative instruments consisting of a cross-currency interest rate swap and a contingent consideration liability relating to an earnout payment on future TrojanLabel operating results.

The following tables provide a summary of the financial assets and liabilities that are measured at fair value as of OctoberJuly 28, 20172018 and January 31, 2017:2018:

 

Assets measured at fair value:

  Fair value measurement at
October 28, 2017
   Fair value measurement at
January 31, 2017
   Fair value measurement at
July 28, 2018
   Fair value measurement at
January 31, 2018
 
(in thousands)  Level 1   Level 2   Level 3   Total   Level 1   Level 2   Level 3   Total   Level 1   Level 2   Level 3   Total   Level 1   Level 2   Level 3   Total 

Money Market Funds (included in Cash and Cash Equivalents)

  $10   $—     $—     $10   $2   $—     $—     $2   $4   $—     $—     $4   $1,798   $—     $—     $1,798 

State and Municipal Obligations (included in Securities Available for Sale)

   —      3,284    —      3,284    —      6,723    —      6,723    —      —      —      —      —      1,511    —      1,511 

Swap Contracts (included in Other Assets)

   —      198      198    —      101    —      101 
  

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

 

Total assets

  $10   $3,284   $—     $3,294   $2   $6,723   $—     $6,725   $4   $198   $—     $202   $1,798   $1,612   $—     $3,410 
  

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

 

Liabilities measured at fair value:

  Fair value measurement at
October 28, 2017
   Fair value measurement at
January 31, 2017
   Fair value measurement at
July 28, 2018
   Fair value measurement at
January 31, 2018
 
(in thousands)  Level 1   Level 2   Level 3   Total   Level 1   Level 2   Level 3   Total   Level 1   Level 2   Level 3   Total   Level 1   Level 2   Level 3   Total 

Swap Contracts (included in Other Liabilities)

  $—     $915   $—     $915   $—     $—     $—     $—     $—     $828   $—     $828   $—     $1,513   $—     $1,513 

Earnout Liability (included in Other Liabilities)

   —      —      916    916    —      —      —      —   

Earnout liability (included in Other Liabilities)

   —      —      15    15    —      —      15    15 
  

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

 

Total liabilities

  $—     $915   $916   $1,831   $—     $—     $—     $—     $—     $828   $15   $843   $—     $1,513   $15   $1,528 
  

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

   

 

 

For our money market funds and municipal obligations, we utilize the market approach to measure fair value. The market approach is based on using quoted prices for identical or similar assets.

We also use the market approach to measure fair value of our derivative instruments. Our derivative liability is comprised of a cross-currency interest rate swap. This derivative instrument wasDerivative instruments were measured at fair value using readily observable market inputs, such as quotations on interest rates and foreign exchange rates, and is classified as Level 2 because it isthey are anover-the-counter contract with a bank counterparty that is not traded in an active market.

The fair value of the earnout liability incurred in connection with the Company’s acquisition of TrojanLabel was determined using the option approach methodology which includes using significant inputs that are not observable in the market and therefore classified as Level 3. Key assumptions in estimating the fair value of the contingent consideration liability included (1) the estimated earnout targets over the next seven years of $0.4$0.5 million-$1.4 million, (2) the probability of success (achievement of the various contingent events) from0.0%-46.8%-0.9% and (3) a risk-adjusted discount rate of approximately1.58%-2.76% 2.68%-4.9% used to adjust the probability-weighted earnout payments to their present value. At each reporting period, the contingent consideration liability is recorded at its fair value with changes reflected in other incomegeneral and administrative expense in the condensed consolidated statements of operations. There was no change in the fair value of the earnout liability for the six months ended July 28, 2018.

Assets and Liabilities Not Recorded at Fair Value on the Consolidated Balance Sheet

As of OctoberJuly 28, 2017,2018 and January 31, 2018, the Company’s long-term debt, including the current portion of long-term debt not reflected in the financial statements at fair value, is reflected in the table below:

 

  Fair Value Measurement at
October 28, 2017
       Fair Value Measurement at
July 28, 2018
   

 

 
(In thousands)  Level 1   Level 2   Level 3   Total   Carrying
Value
   Level 1   Level 2   Level 3   Total   Carrying
Value
 

Long-Term debt and related current maturities

  $—     $—     $9,751   $9,751   $8,648 

Long-Term Debt and related Current Maturities

  $—     $—     $21,306   $21,306   $20,464 
  Fair Value Measurement at
January 31, 2018
     

(In thousands)

  Level 1   Level 2   Level 3   Total   Carrying
Value
 

Long-Term Debt and related Current Maturities

  $—     $—     $24,873   $24,873   $23,372 

On February 28, 2017, the Company entered into a term loan in the amount of $9.2 million with the Bank of America. The fair value of the Company’s long-term debt, including the current portion, of long-term debt is estimated by discounting the future cash flows using current interest rates at which similar borrowings with the same maturities would be made to borrowers with similar credit ratings and is classified as Level 3.

(18) Accumulated Other Comprehensive Loss

The changes in the balance of accumulated other comprehensive loss by component are as follows:

(In thousands)

  Foreign Currency
Translation
Adjustments
   Unrealized Holding
Gain/(Loss)
on Available for
Sale Securities
   Net
Unrealized
Gain (Losses)
on Cash Flow
Hedges
   Total 

Balance at January 31, 2017

  $(1,048  $(8  $—     $(1,056

Other Comprehensive Income (Loss) before reclassification

   210    5    (700   (485

Amounts reclassified from AOCI to Earnings

   —      —      646    646 
  

 

 

   

 

 

   

 

 

   

 

 

 

Other Comprehensive Income (Loss)

   210    5    (54   161 
  

 

 

   

 

 

   

 

 

   

 

 

 

Balance at October 28, 2017

  $(838  $(3  $(54  $(895
  

 

 

   

 

 

   

 

 

   

 

 

 

The amounts presented above in other comprehensive income (loss) are net of any applicable taxes.

(19) Subsequent Event

On November 30, 2017, the Parties entered into a Second Amendment to the Credit Agreement with Bank of America, N.A., which provides for a term loan to the Company in the principal amount of $15.0 million, in addition to a revolving credit facility for the Company and the term loan previously borrowed by ANI APS at the original closing under the Credit Agreement. The Company borrowed the entire $15.0 million upon the closing of the Second Amendment on November 30, 2017 and used the proceeds to repay the entire $14.6 million principal balance of the revolving loan outstanding under the revolving credit facility as of October 28, 2017. The remaining proceeds from the $15.0 million term loan were retained by the Company to be used for general corporate purposes.

Effective upon the closing of the Second Amendment, the principal amount of the revolving credit facility under the Credit Agreement, which had been temporarily increased to $15.0 million pursuant to the First Amendment, was reduced to $10.0 million and the revolving credit facility termination and maturity date was extended from January 31, 2022 to November 22, 2022.

The $15.0 million Term Loan bears interest at a rateper annum equal to, at the Company’s option, either (a) the Eurocurrency Rate (as defined in the Credit Agreement), plus a margin that varies within a range of 1.0% to 1.5% based on the Company’s consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of (i) the federal fund rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate or (iii) the Eurocurrency Rate plus 1.00%, plus a margin that varies within a range of 0.0% to 0.5% based on the Company’s consolidated leverage ratio.

The term loan is required to be paid in quarterly installments on the last day of each fiscal quarter of the Company over the term of the amended Credit Agreement, commencing with its fiscal quarter ending on January 31, 2018. The principal amount of each quarterly installment required to be paid is $750,000, and any remaining principal balance of the term loan is required to be paid on November 30, 2022.

The Company’s obligations in respect to the term loan are secured by the same assets as those securing its obligations under the revolving credit facility under the Credit agreement.

In connection with the Second Amendment, the Company entered into certain hedging arrangements with Bank of America to manage the variable interest rate risk associated with its payments in respect to the $15.0 million term loan.

Item 2.

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Business Overview

This section should be read in conjunction with the AstroNova condensed consolidated financial statements included elsewhere herein and our Annual Report on Form10-K for the fiscal year ended January 31, 2017.2018.

AstroNova is a multi-national enterprise that leverages its proprietary data visualization technologies to design, develop, manufacture, distribute and service a broad range of products that acquire, store, analyze and present data in multiple formats. The Company organizes its structure around a core set of competencies, including research and development, manufacturing, service, marketing and distribution. It markets and sells its products and services through the following two segments:

 

Product Identification—offers product identification and digital label printer hardware, software, servicing contracts, and parts and supplies. Parts and supplies refer toSupplies includes the media (substrate) and ink, toner, and thermal transfer ribbon etc., used with the Company’s printers and the various parts used to maintain the printers.

 

Test and Measurement (T&M)—offers a suite of products and services that acquire and record visual and electronic signal data from local and networked data streamstreams and sensors as well as wired and wireless networks. The recorded data is processed and analyzed and then stored and presented in various visual output formats. The T&M segment also includes a line of aerospace printers that are used to print hard copies of data required for the safe and efficient operation of aircraft, including navigation maps, arrival and departure procedures, flight itineraries, weather maps, performance data, passenger data, and various air traffic control data. Other aerospaceAerospace products also include airborneEthernet switches which are used in military aircraft and rugged networking devices. The Company also markets the media for use with the printers and other devices sold by the T&M segment.vehicles to connect multiple computers or Ethernet devises.

The Company markets and sells its products and services globally through a diverse distribution structure of direct sales personnel, manufacturers’ representatives and authorized dealers that deliver a full complement of branded products and services to customers in our respective markets.

On September 28, 2017, AstroNova entered into an Asset Purchase and License Agreement with Honeywell International, Inc. (the “Honeywell Agreement”) pursuant to acquirewhich it acquired the exclusive perpetual world-wide license to manufacture Honeywell’s narrow format flight deck printers for two aircraft families.

On February 1, 2017, AstroNova completed its acquisitionthe Boeing 737 and Airbus 320 aircraft. Revenue from the sales of TrojanLabel ApS (TrojanLabel), a European manufacturer of digital color label presses and specialty printing systems for a broad range of end markets. TrojanLabelthese printers is being reported as part of our Product IdentificationTest & Measurement segment beginning within the firstthird quarter of fiscal year 2018. Refer to Note 4,5, “Acquisitions,” in ourthe condensed consolidated financial statements included elsewhere in this report for additional details.report.

Results of Operations

Three Months Ended OctoberJuly 28, 20172018 vs. Three Months Ended OctoberJuly 29, 20162017

Revenue by segment and current quarter percentage change over prior year for the three months ended OctoberJuly 28, 20172018 and OctoberJuly 29, 20162017 were:

 

(Dollars in thousands)

  October 28,
2017
   As a
% of
Revenue
 October 29,
2016
   As a
% of
Revenue
 % Change
Over
Prior Year
   July 28,
2018
   As a
% of
Revenue
 July 29,
2017
   As a
% of
Revenue
 % Change
Over
Prior Year
 

Product Identification

  $20,458    71.1 $16,892    72.4 21.1  $21,769    64.4 $20,841    75.8 4.5

T&M

   8,302    28.9 6,450    27.6 28.7   12,038    35.6 6,642    24.2%  81.2
  

 

   

 

  

 

   

 

  

 

   

 

   

 

  

 

   

 

  

 

 

Total

  $28,760    100.0 $23,342    100.0 23.2  $33,807    100.0 $27,483    100.0 23.0
  

 

   

 

  

 

   

 

  

 

   

 

   

 

  

 

   

 

  

 

 

Revenue for the thirdsecond quarter of the current year was $28.8$33.8 million, representing a 23.2%23.0% increase compared to the previous year thirdsecond quarter revenue of $23.3$27.5 million. Revenue through domestic channels for the current year thirdsecond quarter was $18.2$20.0 million, an increase of 8.8%16.3% over the prior year’s thirdsecond quarter. International revenue for the thirdsecond quarter of the current year was $10.6$13.8 million, a 59.8%34.0% increase over the previous year thirdyear’s second quarter and represents 36.8%41% of AstroNova’s third quartersecond quarter’s revenue. The current quarter growth in international revenue was due primarily to increases in revenue for the Company’s ink jet printers and related supplies. Current year thirdsecond quarter international revenue includes a favorable foreign exchange rate impact of $0.3 million.

Hardware revenue in the current quarter was $9.4$12.9 million, an increase compared to the prior year’s thirdsecond quarter revenue of $7.8$8.6 million, primarily due to the increase in revenueTest & Measurement hardware sales of aerospace printers related to the Honeywell Agreement entered into at the end of the Aerospace printer products inthird quarter of the T&M segment, as well as the contribution to hardware revenue from the QuickLabel digital ink jet products and TrojanLabel label presses in the Product Identification segment. prior year.

Supplies revenue in the current quarter was $16.6$17.9 million, a 23.0%9.8% increase over the prior year’s thirdsecond quarter parts and supplies revenue of $13.5$16.3 million.

The current quarter increase in parts and supplies revenue compared to the thirdsecond quarter of the prior year is primarily attributable to increases in revenue of both digital color printer supplies and label and tag products within the Product Identification segment, and related supplies.

as well as an increase in sales of Test & Measurement supplies during the current quarter.

Service repairs and other revenues of $2.8$3.0 million in the current quarter increased 40.0%15.4% from prior year thirdsecond quarter service and other revenues of $2.0$2.6 million, primarily due to an increase in customer demand for parts and repair services in the Test & Measurement segment during the second quarter of the current year third quarter.year.

Current year thirdsecond quarter gross profit was $11.8$13.4 million, a 22.3%30.6% increase fromcompared to prior year thirdsecond quarter gross profit of $9.6$10.3 million. The Company’s current quarter gross profit margin of 41.0%39.6% reflects a 30 basis2.3 percentage point decreaseincrease from the prior year thirdsecond quarter gross profit margin of 41.3%37.3%. The lowerhigher gross profit and related profit margin for the current quarter compared to the prior year is primarily attributable to increased sales and favorable product mix, under absorption of the factory overhead and costs associated with the product line integration related to TrojanLabel and Honeywell TSA.mix.

Operating expenses for the current quarter were $10.2$11.2 million, a 30.2%an increase compared to prior year thirdsecond quarter operating expenses of $7.8$9.3 million. Specifically, selling and marketing expenses for the current quarter increased to $5.5$6.4 million compared to $4.6$5.3 million in the thirdsecond quarter of the prior year due primarily to increasesthe amortization of the Company’s identifiable intangibles purchased in compensation expense, expenses related to the acquisitions of TrojanLabel operations andconnection with the Honeywell intergration,Agreement, as well as an increase in advertising and trade show expenditures.compensation benefits. G&A expenses increased in the thirdsecond quarter to $2.6$2.8 million compared to $1.9$2.3 million in the prior year thirdsecond quarter. The increase is primarily due to an increase in share-based compensationemployee benefits as well asand outside and professional service costs including costs forin the TrojanLabel acquisition.second quarter of the current year. R&D expenses were $2.0 million in the current quarter, compared to $1.3$1.7 million in the prior year third quarter.second quarter with the increase attributable primarily to increased wages and benefits. The R&D spending as a percentage of revenue for the current quarter is 7.1%6.0% compared to 5.7%6.1% for the same period of the prior year, the increase is attributable to the absorption of the TrojanLabel R&D team.year.

Other expense duringin the thirdsecond quarter of fiscal 2019 was $12,000$0.5 million compared to $60,000$16 thousand of other income in the third quarter of the previous year.prior year second quarter. Current year third quarter other expense consists primarily of foreign exchange loss andincludes interest expense on debt partially offset by investment incomeof $0.2 million and income received from the settlement of a legal matter related to patent infringement. Prior year third quarter other expense consists primarily of foreign exchange loss partiallyof $0.3 million. Other income for the second quarter of fiscal 2018 includes foreign exchange gain of $59 thousand and investment income of $68 thousand, offset by investment income.interest expense on debt of $82 thousand and other expense of $30 thousand.

The provision for federal, state and foreign income taxes for the thirdsecond quarter of the current year was $0.2 million. The third quarter$0.5 million which includes an $82 thousand benefit related to windfall tax benefits related to the Company’s stock and reflects an effective tax rate of 12.4% was impacted by a prior period tax benefit received upon the completion of an R&D study, partially offset by current tax increases from the mix of forecastedpre-tax earnings to higher taxing jurisdictions.27.8%. This compares to the prior year’s thirdsecond quarter tax provision on income of $0.6$0.2 million which was impacted by updated projected forecasted income and updated lower foreign tax rates, as well as a $12 thousand benefit related to windfall tax benefits related to the Company’s stock and reflected an effective tax rate of 35.1%24.1%.

The Company reported net income of $1.4$1.2 million or $0.17 per diluted share for the thirdsecond quarter of the current year, and earnings of $0.21 per diluted share, compared toyear. On a comparable basis, net income for the prior year thirdsecond quarter net income of $1.2was $0.7 million and related earnings of $0.15or $0.11 per diluted share. Return on revenue was 4.9%3.5% for the thirdsecond quarter of both fiscal 2018 and 2017.2019 compared to 2.6% for the second quarter of fiscal 2018.

NineSix Months Ended OctoberJuly 28, 20172018 vs. NineSix Months Ended OctoberJuly 29, 20162017

Revenue by product group and current quarter percentage change over prior year for the ninesix months ended OctoberJuly 28, 20172018 and OctoberJuly 29, 20162017 were:

 

(Dollars in thousands)

  October 28,
2017
   As a
% of
Revenue
 October 29,
2016
   As a
% of
Revenue
 % Change
Over
Prior Year
   July 28,
2018
   As a
% of
Revenue
 July 29,
2017
   As a
% of
Revenue
 % Change
Over
Prior Year
 

Product Identification

  $59,945    74.3 $51,126    70.2  17.2  $41,722    63.9 $39,487    76.0  5.7

T&M

   20,756    25.7 21,665    29.8  (4.2)%    23,572    36.1 12,454    24.0  89.3
  

 

   

 

  

 

   

 

  

 

   

 

   

 

  

 

   

 

  

 

 

Total

  $80,701    100.0 $72,791    100.0  10.9  $65,294    100.0 $51,941    100.0  25.7
  

 

   

 

  

 

   

 

  

 

   

 

   

 

  

 

   

 

  

 

 

Revenue for the first ninesix months of the current year was $80.7$65.3 million, representing a 10.9%25.7% increase compared to the previous year’s first ninesix months of revenue of $72.8$51.9 million. Revenue through domestic channels for the first half of the current year was $51.1$39.2 million, comparable toan increase of 19.1% from the prior year domestic revenue of $51.2 million.year. International revenue for the first ninesix months of the current year was $29.6$26.1 million, a 37.0%37.4% increase from the previous year. The current year growth in international revenue was due primarily to increases in revenue for the Company’s ink jet printers and related supplies. The current year’s first ninesix months international revenue included an unfavorable foreign exchange rate impact of $0.1 million$1.1 million.

Hardware revenue in the first ninesix months of the current year remained unchanged fromwas $24.9 million, a 56.6% increase compared to the prior year at $25.3year’s first six months of revenue of $15.9 million as increased revenueprimarily due to the increase in the current yearTest & Measurement hardware sales of aerospace printers related to the QuickLabel digital ink jet printer line andHoneywell Agreement entered into at the TrojanLabel lineend of digital label presses was offset by declines in the Aerospace printer sales to date.third quarter of the prior year.

Supplies revenue in the first nine monthshalf of the current year was $47.7$34.6 million, representing a 15.2%an 11.3% increase over the prior year’s first ninesix months revenue of $41.4$31.1 million. The current year increase in supplies revenue is due primarily to the increase in label and tagdigital color printer supplies product revenue, as well as digital color printer supplies productlabel and tag revenue in the Product Identification segment.

Service repairs and other revenue of $7.7revenues were $5.8 million in the first ninesix months of the current year, increased of $26.2%an increase compared to the prior year. The increase wasyear’s first six months service and other revenues of $4.9 million, primarily due to an increase in customer demand for repair services in the increased parts and repairs revenue in both product groups.Test & Measurement segment during the second quarter of the current year.

Current year first ninesix months gross profit was $31.4$25.5 million, a 6.6%30.4% increase compared tofrom prior yearyear’s first ninesix months gross profit of $29.4$19.6 million. The Company���sCompany’s gross profit margin of 38.9%39.1% in the current year reflects a decreasean increase from the prior yearyear’s first ninesix months gross profit margin of 40.4%37.7%. The lowerhigher gross profit and related margin for the current year compared to the prior year is attributable to lower factory overhead absorption in our manufacturing operationsprimarily due to unfavorablehigher sales and favorable product mix and costs associated with the product line integration related to the TrojanLabel acquisition.mix.

Operating expenses for the first ninesix months of the fiscal year were $28.1$22.1 million, a 15.6%22.3% increase compared to prior yearyear’s first ninesix months operating expenses of $24.3$17.9 million. Selling and marketing expenses for the current year of $16.0$12.9 million increased 12.5%23.7% compared to the previous year’s first ninesix months due primarily to increasesthe amortization of the Company’s identifiable intangibles purchased in compensation and marketing expenditures,connection with the Honeywell Agreement, as well as expenses related to the acquisition of the TrojanLabel operationsincreases in bonus compensation and Honeywell integration.outside service fees. G&A expenses increased to $6.8$5.5 million in the first ninesix months of the current year compared to prior year’s first ninesix months G&A expenses of $5.6$4.2 million primarily due to an increase in share-basedbonus compensation and professional and outside service fees. R&D spending in the first ninesix months of the current year of $5.3was $3.7 million, increased 17.7%a 12.5% increase compared to prior year’s first ninesix months spending of $4.5$3.3 million. Current year spending on R&D represents 6.6%5.7% of revenue compared to the prior year’s first ninesix months level of 6.2%6.4%.

Current year first nine months operating income of $3.3 million resulted in an operating profit margin of 4.1%, compared to prior year first nine months operating income of $5.1 million and related operating margin of 7.0%. The decrease in operating profit and related margin for the current year is due to product mix, lower factory absorption and an increase in operating expenses.

Other expense during the first ninesix months of the current year was $45,000$0.8 million compared to $72,000$33 thousand in the first ninesix months of the previous year. The currentCurrent year decline in other expense is due income related to a settlement of a trademark infringement litigation partially offset by current yearincludes interest expense on debt of $0.4 million and increased foreign exchange loss.loss of $0.5 million, partially offset by investment and other income of $0.1 million. Other expense for fiscal 20172018 included the partial recoveryinterest expense on debt of escrow funds related to the Company’s 2015 RITEC acquisition.$0.1 million, partially offset by investment and other income of $0.1 million.

The Company recognized $0.6 million of income tax expense for the first ninesix months of the current fiscal year. The 24.1% effective tax rate in this period was directly impacted by a $112,000 tax benefit arising from windfall tax benefits related to the Company’s stock and a $78,000 tax benefit related to the expiration of the statute of limitations on a previously uncertain tax position. The prior year’s first six months income tax expense was $0.4 million. The 23.4% effective tax rate for the ninesix months ended October 28,July 29, 2017 was 17.9%, impacted by updated projected forecasted income and updated lower foreign tax rates for the Company’s foreign subsidiaries, as well as a $334,000 prior period$71 thousand tax benefit received uponrelated to the completionstatute of an R&D study, partially offset by currentlimitations expiring on a previously uncertain tax increasesposition and a $27 thousand benefit arising from windfall tax benefits related to the mix of forecastedpre-tax earnings to higher taxing jurisdictions. Prior year first nine months income tax expense of $1.6 million resulted in an effective tax rate of 31.5% for the nine months ended October 29, 2016.Company’s stock.

The Company reported net income of $2.7$2.0 million, or $0.17 per diluted share, for the first ninesix months of the current year, reflectingwhich included $0.8 million ofafter-tax income, or $0.12 per diluted share, as a return onresult of a change in accounting estimates in the first quarter for product cost and operating expenses related to a transition services agreement entered into with Honeywell in connection with the Honeywell Agreement. In addition, during the first quarter of fiscal 2019, a change in accounting estimate for revenue of 3.3% and generating EPS of $0.38subject to customer rebates under the Honeywell Agreement increased net income by $0.3 million or $0.05 per diluted share.    In the prior year’s first ninesix months, the Company recognized net income of $3.5$1.2 million, reflecting a returnor $0.17 per diluted share. Return on revenue was 3.1% for the first six months of 4.8% and EPSfiscal 2019 compared to 2.4% for the first six months of $0.46 per diluted share.

fiscal 2018.

.

Segment Analysis

The Company reports two segments: Product Identification and Test & Measurement (T&M) and evaluates segment performance based on the segment profit before corporate and administrativefinancial administration expenses. Summarized below are the Revenue and Segment Operating Profit for each reporting segment:

 

  Three Months Ended Nine Months Ended   Three Months Ended   Six Months Ended 
  Revenue   Segment Operating Profit Revenue   Segment Operating Profit   Revenue   Segment
Operating Profit
   Revenue   Segment
Operating Profit
 

(In thousands)

  October 28,
2017
   October 29,
2016
   October 28,
2017
 October 29,
2016
 October 28,
2017
   October 29,
2016
   October 28,
2017
 October 29,
2016
   July 28,
2018
   July 29,
2017
   July 28,
2018
 July 29,
2017
   July 28,
2018
   July 29,
2017
   July 28,
2018
 July 29,
2017
 

Product Identification

  $20,458   $16,892   $2,657  $2,443  $59,945   $51,126   $7,761  $7,069   $21,769   $20,841   $2,159  $2,612   $41,722   $39,487   $3,820  $5,104 

T&M

   8,302    6,450    1,572  1,282  20,756    21,665    2,300  3,625    12,038    6,642    2,814  657    23,572    12,454    5,071  728 
  

 

   

 

   

 

  

 

  

 

   

 

   

 

  

 

   

 

   

 

   

 

  

 

   

 

   

 

   

 

  

 

 

Total

  $28,760   $23,342    4,229  3,725  $80,701   $72,791    10,061  10,694   $33,807   $27,483    4,973  3,269   $65,294   $51,941    8,891  5,832 
  

 

   

 

     

 

   

 

      

 

   

 

      

 

   

 

    

Corporate Expenses

       2,597  1,891       6,780  5,566        2,808  2,327        5,462  4,183 
      

 

  

 

      

 

  

 

       

 

  

 

       

 

  

 

 

Operating Income

       1,632  1,834       3,281  5,128        2,165  942        3,429  1,649 

Other Expense—Net

       (12 (60      (45 (72

Other Income (Expense), Net

       (512 16        (782 (33
      

 

  

 

      

 

  

 

       

 

  

 

       

 

  

 

 

Income Before Income Taxes

       1,620  1,774       3,236  5,056        1,653  958        2,647  1,616 

Income Tax Provision

       201  623       579  1,595        459  231        639  378 
      

 

  

 

      

 

  

 

       

 

  

 

       

 

  

 

 

Net Income

      $1,419  $1,151      $2,657  $3,461       $1,194  $727       $2,008  $1,238 
      

 

  

 

      

 

  

 

       

 

  

 

       

 

  

 

 

Product Identification

Revenue from the Product Identification segment increased 21.1% to $20.5 million4.5% in the thirdsecond quarter of the current year, from $16.9with revenue of $21.8 million compared to $20.8 million in the same period of the prior year. Hardware revenue increased 13.4%8.2% compared to prior year primarily due primarily to increasedan increase in demand for our QuickLabel line of digital colorthe new TrojanLabel printers as well asproducts. The current year second quarter also received a solid contribution from the TrojanLabelsupplies product line of label presses. Supplies revenue which increased 21.1%5.0% from the same period in the prior yearyear. The current quarter increase in supplies revenue is due to increasedthe continued increase in demand for digital color printer supplies, which have experienced double-digit growth in the current year second quarter compared to the same period in the prior year. The increase in sales of label and labels and tags products.tag products for the current quarter also contributed to the increase in supplies revenue. The Product Identification segment current quarter segment operating profit was $2.7$2.2 million, reflecting a profit margin of 13.0%, compared9.9%. This compares to the prior year’s thirdsecond quarter segment profit of $2.4$2.6 million and related profit margin of 14.5 %.12.5%. The decreasedecline in Product Identification current year thirdsecond quarter segment operating margin is primarily due to unfavorable product mixprofit and increased manufacturing and operating costs.

Revenues from the Product Identification segment increased 17.2% to $59.9 million in the first nine months of the current year from $51.1 million in the same period of the prior year. The increase is primarily attributable to double-digit growth in the demand for label and tag products and digital color printer supplies products, as well as a 23.8% increase in revenue from the hardware product group for the current year. Product Identification current year segment operating profit of $7.8 million was a 9.8% increase from prior year segment profit of $7.1 million, however current year profit margin of 12.9% is a slight decline from prior year profit margin of 13.8 %. The increase in current year segment operating profit is primarily due to higher revenue, while the decrease in segment operating profit margin is primarily due to product mix and higher manufacturing and operating expenses.

Revenues from the Product Identification segment increased 5.7% to $41.7 million in the first six months of the current year from $39.5 million in the same period of the prior year, attributable to an increase in supplies revenue of 6.0% due to increased demand for digital color printer supplies products, as well as label and tag products. The increase in current year revenue also received a contribution from increased sales of TrojanLabel printers, which experienced double-digit growth in the current year. Product Identification current year segment operating profit of $3.8 million and profit margin of 9.2% declined from the prior year segment operating profit of $5.1 million and related profit margin of 12.7 %. The decrease in current year segment operating profit and margin is primarily due to product mix and higher manufacturing and operating expenses.

Test & Measurement—T&M

Revenue from the T&M segment was $8.3$12.0 million for the thirdsecond quarter of the current fiscal year, a 28.7%representing an 81.2% increase fromcompared to revenue of $6.5$6.6 million for the same period in the prior year. The increase is due primarily to the increased revenueincrease in the Aerospace product grouphardware sales of aerospace printers as a result of fulfilling orders placed in earlier periods as well as an increase in salesthe Honeywell Agreement entered into at the end of certain legacy data recorders.the third quarter of the prior year. The T&M thirdsegment second quarter segment operating profit of $1.6$2.8 million and 18.9%23.4% profit margin compared to the prior year segment operating profit of $1.3$0.7 million and related operating margin of 19.9%9.9%. The lowerincrease in segment operating profit and related margin iswere due to increased operating costs.higher sales revenue and favorable product mix.

Revenue from the T&M segment was $20.8$23.6 million for the first ninesix months of the current fiscal year, a 4.2% decreasean 89.3% increase compared to revenuesales of $21.7$12.5 million for the same period in the prior year. The current year decreaseincrease is attributable to a 12.9% decrease in Aerospace hardware product line revenue, compareddue primarily to the same periodincrease in hardware sales of aerospace printers as a result of the Honeywell Agreement entered into at the end of the third quarter of the prior year. The segment’s first ninesix months operating profit of $2.3$5.1 million resulted in a 11.1%21.5% profit margin compared to prior year segment operating profit of $3.6$0.7 million and related operating margin of 16.7%5.8%. The lowerhigher segment operating profit and related profit margin for the current year is due to lowerhigher revenue unfavorableand product mix and higher operating costs.mix.

Financial Condition and Liquidity

Based uponOverview

Generally, our primary source of liquidity is cash generated from operating activities. We may also utilize amounts available under our revolving credit facility, as described below, to supplement operating activities and to fund a portion of our capital expenditures, contractual contingent consideration obligations, and future acquisitions. We believe that our current working capital position, current operating planslevel of cash and expected business conditions, we expect to fund our short and long-term working capital needs, capital expenditures and acquisition requirements primarily using internal funds, and we believe thatshort-term financing capabilities along with future cash provided byflows from operations will be sufficient to meet our operating and capital needs for at least the next 12 months.

We may also utilize amountsDuring the first quarter of fiscal 2019, we converted our securities available for sale to cash. In the second quarter of fiscal 2019, we drew $3.0 million on our revolving credit facility, of which $1.5 million was repaid during the quarter and $1.5 million remained outstanding as of July 28, 2018. Our cash and cash equivalents at the end of the second quarter were $5.9 million and we have $8.5 million remaining available under our securedrevolving credit facility, as described below, to fund a portion of our capital expenditures, contractual contingent consideration obligations, and future acquisitions.facility.

Indebtedness

On February 28, 2017, wethe Company and its wholly owned Danish subsidiaries, ANI ApS and TrojanLabel ApS (together, the “Parties”), entered into a credit agreementCredit Agreement with Bank of America, N.A., which (the “Lender”). The Credit Agreement provided for a secured credit facility consisting of a $9.2 million term loan to ANI ApS andin the principal amount of $9.2 million. The Credit Agreement also provided for a $10.0 million revolving credit facility available to the Company for general corporate purposes.

In connection with the Company. OnHoneywell Purchase and License Agreement, on September 28, 2017, the CompanyParties entered into thea First Amendment to the Credit Agreement whichwith the Lender. The First Amendment amended the existing Credit Agreement to permit the Honeywell Asset Purchase and License Agreement and temporarily increased the amount available for borrowing under the revolving credit linefacility from $10.0 million to $15.0 million. The initial upfront payment of $14.6 million for the Honeywell Agreement was paid using borrowings under the Company’s revolving credit facility.

On November 30, 2017, the Parties entered into a Second Amendment to the Credit Agreement with the Lender. The $9.2 millionSecond Amendment provided for a term loan bears interest at a rate per annum equal to the LIBOR rate plusCompany in the principal amount of $15.0 million, in addition to the revolving credit facility for the Company and the term loan previously borrowed by ANI ApS at the original closing under the Credit Agreement. The proceeds from the term loan were used to repay the entire $14.6 million principal balance of the revolving loans outstanding under the revolving credit facility. The principal amount of the revolving credit facility which had been temporarily increased to $15.0 million was reduced to $10.0 million effective upon closing of the Second Amendment and the maturity date was extended to November 30, 2022.

On April 17, 2018, the Parties entered into a marginThird Amendment to the Credit Agreement with the Lender. The Third Amendment provides that varies withinno “Immaterial Subsidiary” will be required to become a rangeguarantor or securing party under (unless requested by the Lender during default) or have its equity pledged pursuant to the Credit Agreement. The Third Amendment defines “Immaterial Subsidiary” as any subsidiary of 1.0% to 1.5% based on the Company’sCompany with (a) consolidated leverage ratio. total assets that do not exceed 5.0% of the consolidated total assets of the Company and its subsidiaries and (b) revenues that do not exceed 5.0% of the consolidated revenues of the Company and its subsidiaries, as of the last day of the most recent fiscal quarter; provided that Immaterial Subsidiaries shall not account for, in the aggregate, more than 10% the of consolidated total assets or consolidated revenues of the Company and its subsidiaries.

In connection with our entry into the credit agreement,Credit Agreement, AstroNova and ANI ApS entered into acertain hedging arrangementarrangements with the Lender to manage the variable interest rate risk and currency risk associated with its payments in respect of the term loan. Under these arrangements, payments of principal andloans.

Revolving credit loans may be borrowed, at the Company’s option, in U.S. Dollars or, subject to certain conditions, Euros, British Pounds, Canadian Dollars or Danish Krone. Amounts borrowed under the revolving credit facility bear interest in respect of approximately $8.9 million of the principal of the term loan will be made in Danish Krone, and interest on such principal amount will be payable at a fixedrate per annum equal to, at the Company’s option, either (a) the LIBOR rate (or in the case of 0.67% per annum forrevolving credit loans denominated in a currency other than U.S. Dollars, the entire term, subject onlyapplicable quoted rate), plus a margin that varies within a range of 1.0% to potential increases1.5% based on the Company’s consolidated leverage ratio, or (b) a fluctuating reference rate equal to the highest of 0.25%(i) the federal funds’ rate plus 0.50%, (ii) Bank of America’s publicly announced prime rate or 0.50% per annum(iii) the LIBOR rate plus 1.00%, plus a margin that varies within a range of 0.0% to 0.5% based on the Company’s consolidated leverage ratio. ReferThe Company is required to Note 12, “Debt,” to our condensed consolidated financial statements included elsewhere in this quarterly report for additional information regarding our secured credit facility.

As of October 28, 2017,pay a commitment fee on the Company has used $14.6 millionundrawn portion of the revolving credit facility for the initial payment of the Honeywell Asset Purchase and License Agreement and there is $400,000 remaining available. Refer to Note 11, “Revolving Credit Facility” to our condensed consolidated financial statements included elsewhere in this quarterly report for additional information regarding our revolving credit facility.

Refer to Note 13, “Derivative Financial Instruments and Risk Management,” to our condensed consolidated financial statements included elsewhere in this quarterly report for additional information regarding our hedging arrangements.

Subsequent to quarter end, on November 30, 2017, the Parties entered into the Second Amendment of the Credit Agreement. The Second Amendment provides for a term loan to the Company in the principal amount of $15.0 million, in addition to a revolving credit facility for the Company and the term loan previously borrowed by ANI Aps at the original closing under the Credit Agreement. The Company borrowed the entire $15.0 million upon the closingrate of the Second Amendment on November 30, 2017 and used the proceeds to repay the entire $14.6 million principal balance of the revolving loan outstanding0.25% per annum. Outstanding borrowings under the revolving credit facility asline during fiscal 2019 bear interest at an annual rate of October5.5% and the Company has accrued $17.5 thousand on the outstanding obligation for the six months ended July 28, 2017. 2018.

The remaining proceeds fromobligations of ANI ApS in respect of the $9.2 million term loan are guaranteed by the Company and TrojanLabel. The Company’s obligations in respect of the $15.0 million term loan, were retainedrevolving credit facility and its guarantee in respect of the ANI ApS term loan are secured by substantially all of the assets of the Company (including a pledge of a portion of the equity interests held by the Company in ANI ApS and the Company’s wholly-owned German subsidiaryAstro-Med GmbH), subject to be used for general corporate purposes. certain exceptions.

The principal amountParties must comply with various customary financial andnon-financial covenants under the Credit Agreement.

The Lender is entitled to accelerate repayment of the loans and to terminate its revolving credit facilitycommitment under the Credit Agreement which had been temporarily increased to $15.0 million pursuant to the First Amendment, was reduced to $10.0 million effective upon the closingoccurrence of any of various customary events of default.

As of July 28, 2018, we believe the Company is in compliance with all of the Second Amendment, andcovenants in the revolving credit facility termination and maturity date was extended from January 31, 2022 to November 22, 2022. Refer to Note 19 “Subsequent Event” to our condensed consolidated financial statements included elsewhere in this quarterly report for further details.Credit Agreement.

Cash Flow

The Company’s statements of cash flows for the ninesix months ended OctoberJuly 28, 20172018 and OctoberJuly 29, 20162017 are included on page 6 of this report. Net cash flows providedused by operating activities were $2.0was $2.6 million for the first ninesix months of fiscal 20182019 compared to $7.3net cash provided of $1.7 million for the same period of the previous year. The decreaseincrease in operatingnet cash flow is related to lower net income and higher working capital requirementsused by operations for the first ninesix months of the current year is primarily due to payments of prior quarters accrued expenses to Honeywell under the TSA agreement, slower collections on accounts receivable related to Honeywell customers and the increase in inventory to support the transition of the production of printers to the West Warwick facility in accordance with the Honeywell TSA. The combination of these factors on accounts receivable, inventory, accounts payable and accrued expenses decreased cash by $7.6 million in the first six months of fiscal 2019, compared to a decrease of $1.6 million for the same period in the previous year. Excluding the impact of the TrojanLabel acquisition, thefiscal 2018. The accounts receivable balance increased to $16.5$24.0 million at the end of the thirdsecond quarter from $15.7compared to $22.4 million atyear-end, year end and the accounts receivable collection cycle increased to 59 days compared to 55 days at year end. The inventory balance was 48 days sales outstanding$28.4 million at the end of the thirdsecond quarter of fiscal 20182019, compared to 50$27.6 million at year end and inventory days at fiscal 2017year-end. Inventoryon hand increased to $21.5 million after excluding the TrojanLabel and Honeywell acquisitions125 days at the end of the thirdcurrent quarter compared to $ 19.5 million atyear-end. Inventoryfrom 124 days on hand increased to 126 days on hand at the end of the third quarter from 114 days atyear-end.prior year end.

The Company’s cash, cash equivalents and investments at the end of the third quarter were $11.8 million, compared to $24.8 million atyear-end.The decreased cash and investment position at OctoberJuly 28, 2017,2018, primarily resulted from $11.2 million ofincreased cash used for the purchasein operations as discussed above, principal payments of the Company’s common stock from the Ondis’ trust,long-term debt of $2.9 million, dividends paid of $1.5$1.0 million and cash used to acquire property, plant and equipment of $1.7$0.8 million.

The Company’s backlog increased 20.9%14.5% fromyear-end to $21.3$24.5 million at the end of the thirdsecond quarter of fiscal 2018.2019.

Contractual Obligations, Commitments and Contingencies

Except as set forth below, thereThere have been no material changes to our contractual obligations as disclosed in the Company’s Annual Report on Form10-K for the fiscal year ended January 31, 2017,2018, other than those which occur in the ordinary course of business.

The Company is subject to minimum royalty payments of $15.0 million over the next ten years in connection with the Honeywell Agreement.

On February 28, 2017, the Parties entered into a Credit Agreement with Bank of America, N.A. which provides for a term loan in the amount of $9.2 million. Future minimum principal and interest payments are approximately $9.1 million through the term loan’s maturity date of January 31, 2022.

Subsequent to quarter end, on November 30, 2017, the Parties entered into the Second Amendment to the Credit Agreement with Bank of America, N.A. The Second Amendment provides for a term loan to the Company in the amount of $15.0 million. Proceeds from the term loan were used to repay the entire $14.6 million principal balance outstanding on the revolving credit facility. Future minimum principal and interest payments are approximately $15.6 million through the term loan’s maturity date of November 30, 2022.

Critical Accounting Policies, Commitments and Certain Other Matters

In the Company’s Annual Report on Form10-K for the fiscal year ended January 31, 2017,2018, the Company’s most critical accounting policies and estimates upon which our financial status depends were identified as those relating to revenue recognition, warranty claims, bad debts, inventories, income taxes, long-lived assets, goodwill and share-based compensation. We considered the disclosure requirements of Financial Release (“FR”) 60 regarding critical accounting policies andFR-61 regarding liquidity and capital resources, certain trading activities and related party disclosures, and concluded that nothing materially changed during the quarter that would warrant further disclosure under these releases.

Forward-Looking Statements

This Quarterly Report on Form10-Q may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. Factors which could cause actual results to differ materially from those anticipated include, but are not limited to (a) general economic, financial and business conditions; (b) declining demand in the test and measurement markets, especially defense and aerospace; (c) competition in the specialty printer industry; (d) ability to develop market acceptance of our products and effective design of customer required features; (e) competition in the data acquisition industry; (f) the impact of changes in foreign currency exchange rates on the results of operations; (g) the ability to successfully integrate acquisitions and realize benefits from divestitures; (h) the business abilities and judgment of personnel and changes in business strategy; (i) the efficacy of research and development investments to develop new products; (j) the launching of significant new products which could result in unanticipated expenses; (k) bankruptcy or other financial problems at major suppliers or customers that could cause disruptions in the Company’s supply chain or difficulty in collecting amounts owed by such customers; and (l) other risks included under“Item 1A-Risk Factors” in the Company’s Annual Report on Form10-K for the fiscal year ended January 31, 2017.2018. We assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We have exposureDuring the six months ended July 28, 2018, there were no material changes to financialour market risks, including changesrisk disclosures as set forth in foreign currency exchange ratesPart II, Item 7A “Quantitative and interest rates.

Foreign Currency Exchange Risk

The functional currencies of our foreign subsidiaries and branches are the local currencies – the British Pound in the UK, the Canadian Dollar in Canada, the Danish Krone in Denmark and the Euro in France and Germany. Accordingly, the effects of exchange rate fluctuations on the net assets of these foreign subsidiaries’ operations are accounted for as translation gains or losses in accumulated other comprehensive income (loss) within stockholders’ equity. We do not believe that a change of 10% in such foreign currency exchange rates would have a material impact on our consolidated financial position or results of operations.

The Company is also subject to risk from the effects of exchange rate movements in foreign currency through its borrowings, specifically our U.S. dollar borrowing at our Danish Krone functional currency subsidiary. We entered into a cross-currency interest rate swap to hedge the foreign currency cash flow and interest rate exposures related to the U.S. Dollar floating-rate debt included on the books of our Danish subsidiary (functional currency is Danish Krone). A 10% increase in the rate of exchange of Danish Krone to U.S. Dollars would result in an increaseQualitative Disclosures About Market Risk” in our debt balance of approximately $1.1 million, and a 10% decrease inAnnual Report on Form10-K for the rate of exchange of Danish Krone to U.S. Dollars would result in a decrease of our debt balance of approximately $0.7 million. This impact is mitigated through our cross-currency interest rate swap.

Interest Rate Risk

As of October 28, 2017, the Company’s debt portfolio was comprised of U.S. Dollar, floating-rate borrowings on the books of our Danish subsidiary. We entered into a cross-currency interest rate swap to convert the floating-rate foreign currency debt on our foreign subsidiary, to a fixed-rate functional currency debt. Generally, the fair market value of fixed interest rate debt will increase as interest rates fall and decrease as interest rates rise. If Danish Krone interest rates were to decrease by 50 basis points, the fair value of the Company’s debt would increase by approximately $0.2 million. If interest rates were to increase by 50 basis points, the fair value of the Company’s debt would decrease by approximately $0.2 million.

At October 28, 2017, we had cash and cash equivalents of approximately $8.5 million, of which $2.7 million is held in US bank accounts and $5.8 million is held in foreign bank accounts. We also have $3.3 million of securities available for sale, which include state and municipal securities.

with maturities ranging from one month to two years. We do not enter into investments for trading or speculative purposes. All funds are available for working capital and other operating requirements. We do not believe that we have material exposure to changes in fair value of these investments as a result of changes in interest rates due to the short-term nature of these investments.year ended January 31, 2018.

 

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant toRule 13a-15(b) under the Securities Exchange Act of 1934, as amended (Exchange Act). Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to have materially affected, our internal control over financial reporting.

PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings

There are no pending or threatened legal proceedings against the Company believed to be material to the financial position or results of operations of the Company.

 

Item 1A.

Risk Factors

In addition to the other information set forth in this Quarterly Report on Form10-Q, one should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” in the Company’s Annual Report on Form10-K for the fiscal year ended January 31, 2017,2018, which could materially affect our business, financial condition or future operating results. The risks described in our Annual Report on10-K are not the only risks that could affect our business, as additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results as well as adversely affect the value of our common stock.

There have been no material updates to the risk factors previously disclosed in the Company’s Annual Report onForm 10-K for the fiscal year ended January 31, 2017.2018.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

During the thirdsecond quarter of fiscal 2018,2019, the Company made the following repurchases of its common stock:

 

   Total Number
of Shares
Repurchased
  Average
Price paid
Per Share
  Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs
   Maximum Number
of Shares That
May Be Purchased
Under The Plans
or Programs
 

Aug1- Aug 31

   —    $—     —      390,000 

Sept 1—Sept 30

   813(a)  $13.75(a)   —      390,000 

Oct 1—Oct 31

   —    $—     —      390,000 
Total Number
of Shares
Repurchased
Average
Price paid
Per Share
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans
or Programs
Maximum Number
of Shares That
May Be Purchased
Under The Plans
or Programs

May1-May 31

8,631(a)(b)$19.52(a)(b)—  390,000

June 1-June 30

14,506(c)(d)$18.36(c)(d)—  390,000

July 1-July 31

—  $—  —  390,000

 

(a)An employee

Employees of the Company delivered 8136,076 shares of the Company’s common stock toward the satisfaction of taxes due with respect to satisfy the exercise price for 1,200 stock options exercised.vesting of restricted shares. The shares delivered were valued at an average market value of $13.75$19.65 per share and are included with treasury stock in the consolidated balance sheet. This transaction did not impact the number of shares authorized for repurchase under the Company’s current repurchase program.

(b)

A director of the Company delivered 2,555 shares of the Company’s common stock to satisfy the exercise price for 5,000 stock options exercised. The shares delivered were valued at an average market value of $19.20 per share and are included with treasury stock in the consolidated balance sheet. This transaction did not impact the number of shares authorized for repurchase under the Company’s current repurchase program.

(c)

An employee of the Company delivered 2,048 shares of the Company’s common stock toward the satisfaction of taxes due with respect to vesting of restricted shares. The shares delivered were valued at an average market value of $18.25 per share and are included with treasury stock in the consolidated balance sheet. This transaction did not impact the number of shares authorized for repurchase under the Company’s current repurchase program.

(d)

Employees of the Company delivered 12,458 shares of the Company’s common stock to satisfy the exercise price for 19,075 stock options exercised. The shares delivered were valued at an average market value of $18.38 per share and are included with treasury stock in the consolidated balance sheet. This transaction did not impact the number of shares authorized for repurchase under the Company’s current repurchase program.

Item 6.

Exhibits

 

    3A  Restated Articles of Incorporation of the Company and all amendments thereto (incorporated by reference to Exhibit 3A to the Company’s Quarterly Report on Form10-Q for the quarter ended April 30, 2016).
    3B  By-laws of the Company as amended to date (incorporated by reference to Exhibit 3B to the Company’s Annual Report on Form10-K10-Q for the fiscal year ended January 31, 2008 (File no.000-13200)).
    4.2AstroNova, Inc. 2018 Equity Incentive Plan (incorporated by reference to Appendix A to the Registrant’s definitive proxy statement on Schedule 14A filed with the SEC on May 4, 2018)
10.1  Second Amendment to the CreditForm of Performance-based Restricted Stock Unit Award  Agreement dated November 30, 2017, by and among AstroNova, Inc., ANI ApS, Trojan Label ApS and Bank of America, N.A. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form8-K event dated November 30, 2017, filed with the SEC on December 6, 2017)June 4, 2018).
*10.2  Asset Purchase and LicenseForm of Restricted Stock Unit Agreement dated September 28, 2017, by and between AstroNova, Inc. and Honeywell International, Inc. (time-based  vesting) (incorporated by referencedreference to Exhibit 10.110.2 to the Company’s Current Report on Form8-K event date September 28, 2017, filed with the SEC on OctoberJune 4, 2017)2018).
  10.3  Amended and Restated AstroNova, Inc. EmployeeForm of Incentive Stock Purchase PlanOption (incorporated by reference to Exhibit 10.110.3 to the Company’s Current Report on Form8-K event date November 20, 2017, filed with the SEC on November 27, 2017)June 4, 2018).
  10.4Form of Non-statutory Stock  Option (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form8-K filed with the SEC on June 4, 2018).
  10.5Form of Non-statutory Stock Option  (Non-employee Director) (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form8-K filed with the SEC on June 4, 2018).
  10.6Form of Restricted Stock  Agreement (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form8-K filed with the SEC on June 4, 2018).
  10.7Form of Non-employee Director Restricted Stock  Agreement (incorporated by reference to Exhibit 10.7 to the Company’s Current Report on Form8-K filed with the SEC on June 4, 2018).
  31.1  Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  31.2  Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  32.1  Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  32.2  Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  101  The following materials from Registrant’s Quarterly Report onForm10-Q for the period ended OctoberJuly 28, 2017,2018, formatted in XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Cash Flows, and (vi) the Notes to the Condensed Consolidated Financial Statements. Filed electronically herein.

*Portions of this exhibit which have been granted confidential treatment have been omitted.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  

ASTRONOVA, INC.

(Registrant)

Date: December 7, 2017September 5, 2018  By 

/s/ Gregory A. Woods

   Gregory A. Woods,
   President and Chief Executive Officer
   (Principal Executive Officer)
  By 

/s/ Joseph P. O’ConnellDavid S. Smith

   Joseph P. O’Connell,David S. Smith,
   Vice President, and Interim Chief Financial Officer and Treasurer (Principal
Accounting Officer and Principal Financial Officer)

 

3136